disease,drug,phase,status,target,num_ev_strings
breast carcinoma,PACLITAXEL,2,Completed,TUBB,110
breast carcinoma,DOCETAXEL,2,Completed,TUBB,102
non-small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,70
non-small cell lung carcinoma,DOCETAXEL,2,Completed,TUBB,69
neoplasm,PACLITAXEL,1,Completed,TUBB,60
prostate carcinoma,DOCETAXEL,2,Completed,TUBB,53
breast carcinoma,DOCETAXEL,3,Completed,TUBB,52
lymphoma,VINCRISTINE,2,Completed,TUBB,52
neoplasm,DOCETAXEL,1,Completed,TUBB,50
breast carcinoma,PACLITAXEL,1,Completed,TUBB,48
breast carcinoma,PACLITAXEL,3,Completed,TUBB,44
lung carcinoma,PACLITAXEL,2,Completed,TUBB,43
ovarian carcinoma,PACLITAXEL,2,Completed,TUBB,43
breast carcinoma,PACLITAXEL,2,Recruiting,TUBB,39
breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,37
lung carcinoma,DOCETAXEL,2,Completed,TUBB,36
non-small cell lung carcinoma,DOCETAXEL,3,Completed,TUBB,36
lymphoma,VINCRISTINE,3,Completed,TUBB,31
non-small cell lung carcinoma,PACLITAXEL,1,Completed,TUBB,29
non-small cell lung carcinoma,DOCETAXEL,2,Terminated,TUBB,26
breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,24
breast carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,24
breast carcinoma,VINORELBINE,2,Completed,TUBB,23
ovarian carcinoma,PACLITAXEL,1,Completed,TUBB,23
breast carcinoma,PACLITAXEL,2,Terminated,TUBB,21
breast carcinoma,DOCETAXEL,2,Unknown status,TUBB,21
breast carcinoma,DOCETAXEL,1,Completed,TUBB,21
head and neck malignant neoplasia,PACLITAXEL,2,Completed,TUBB,21
prostate carcinoma,DOCETAXEL,1,Completed,TUBB,21
breast carcinoma,DOCETAXEL,2,Terminated,TUBB,21
non-small cell lung carcinoma,PACLITAXEL,3,Completed,TUBB,21
cancer,DOCETAXEL,1,Completed,TUBB,20
leukemia,VINCRISTINE,2,Completed,TUBB,20
cancer,PACLITAXEL,1,Completed,TUBB,20
non-small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,19
esophageal carcinoma,PACLITAXEL,2,Completed,TUBB,19
non-small cell lung carcinoma,VINORELBINE,2,Completed,TUBB,19
non-small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,19
breast neoplasm,PACLITAXEL,2,Completed,TUBB,19
leukemia,VINCRISTINE,3,Completed,TUBB,18
breast carcinoma,PACLITAXEL,1,Recruiting,TUBB,18
lung carcinoma,PACLITAXEL,3,Completed,TUBB,18
breast carcinoma,PACLITAXEL,2,Unknown status,TUBB,18
non-small cell lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,18
prostate carcinoma,DOCETAXEL,2,Terminated,TUBB,18
head and neck malignant neoplasia,DOCETAXEL,2,Completed,TUBB,17
peritoneal neoplasm,PACLITAXEL,2,Completed,TUBB,17
pancreatic carcinoma,PACLITAXEL,1,Recruiting,TUBB,17
breast carcinoma,IXABEPILONE,2,Completed,TUBB,17
ovarian carcinoma,PACLITAXEL,3,Completed,TUBB,17
peritoneal neoplasm,PACLITAXEL,1,Completed,TUBB,16
Fallopian Tube Carcinoma,PACLITAXEL,2,Completed,TUBB,16
prostate adenocarcinoma,DOCETAXEL,2,Completed,TUBB,16
non-small cell lung carcinoma,PACLITAXEL,3,Recruiting,TUBB,15
gout,COLCHICINE,4,n/a,TUBB,15
neoplasm,PACLITAXEL,1,Recruiting,TUBB,15
non-small cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,15
non-small cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB,15
pancreatic carcinoma,PACLITAXEL,2,Recruiting,TUBB,15
lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,15
lung carcinoma,PACLITAXEL,1,Completed,TUBB,15
ovarian carcinoma,PACLITAXEL,2,Terminated,TUBB,15
breast carcinoma,PACLITAXEL,3,Recruiting,TUBB,14
breast carcinoma,ERIBULIN,2,Completed,TUBB,14
gastric carcinoma,DOCETAXEL,2,Completed,TUBB,14
breast carcinoma,VINORELBINE,2,Terminated,TUBB,14
breast neoplasm,DOCETAXEL,2,Completed,TUBB,14
lymphoma,VINCRISTINE,2,Unknown status,TUBB,14
pancreatic carcinoma,DOCETAXEL,2,Completed,TUBB,14
breast carcinoma,DOCETAXEL,2,Recruiting,TUBB,14
non-small cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB,13
lymphoma,VINCRISTINE,3,Unknown status,TUBB,13
breast carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,13
ovarian carcinoma,DOCETAXEL,2,Completed,TUBB,13
non-small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,13
non-small cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,13
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,2,Recruiting,TUBB,13
breast carcinoma,PACLITAXEL,4,n/a,TUBB,12
lymphoma,VINCRISTINE,1,Completed,TUBB,12
diffuse large B-cell lymphoma,VINCRISTINE,2,Completed,TUBB,12
breast carcinoma,PACLITAXEL,3,Unknown status,TUBB,12
acute lymphoblastic leukemia,VINCRISTINE,2,Completed,TUBB,12
pancreatic carcinoma,PACLITAXEL,1,Completed,TUBB,12
non-small cell lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,12
non-small cell lung carcinoma,DOCETAXEL,3,Terminated,TUBB,11
non-small cell lung carcinoma,DOCETAXEL,1,Completed,TUBB,11
ovarian carcinoma,PACLITAXEL,2,Recruiting,TUBB,11
breast carcinoma,DOCETAXEL,3,Unknown status,TUBB,11
prostate carcinoma,DOCETAXEL,3,Completed,TUBB,11
non-small cell lung carcinoma,VINORELBINE,3,Completed,TUBB,11
breast neoplasm,DOCETAXEL,3,Completed,TUBB,11
peritoneal neoplasm,PACLITAXEL,3,Completed,TUBB,11
pancreatic adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,11
non-small cell lung carcinoma,PACLITAXEL,4,n/a,TUBB,11
pancreatic carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,11
breast carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,11
non-small cell lung carcinoma,VINORELBINE,2,Unknown status,TUBB,10
acute lymphoblastic leukemia,VINCRISTINE,2,Recruiting,TUBB,10
ovarian carcinoma,PACLITAXEL,1,Recruiting,TUBB,10
non-small cell lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,10
acute lymphoblastic leukemia,VINCRISTINE,4,Completed,TUBB,10
non-small cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB,10
prostate carcinoma,PACLITAXEL,2,Completed,TUBB,10
non-small cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,10
neoplasm,ERIBULIN,1,Completed,TUBB,10
melanoma,PACLITAXEL,2,Completed,TUBB,10
breast carcinoma,PACLITAXEL,1,Terminated,TUBB,10
lung carcinoma,VINORELBINE,2,Completed,TUBB,10
Fallopian Tube Carcinoma,PACLITAXEL,1,Completed,TUBB,10
non-small cell lung carcinoma,PACLITAXEL,1,Recruiting,TUBB,9
neuroblastoma,VINCRISTINE,2,Completed,TUBB,9
lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,9
non-small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,9
non-small cell lung carcinoma,DOCETAXEL,4,n/a,TUBB,9
prostate carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,9
prostate carcinoma,DOCETAXEL,2,Recruiting,TUBB,9
Familial Mediterranean fever,COLCHICINE,4,n/a,TUBB,9
lymphoma,VINBLASTINE,2,Completed,TUBB,9
lymphoma,VINCRISTINE,3,"Active, not recruiting",TUBB,9
peritoneal neoplasm,PACLITAXEL,2,Terminated,TUBB,9
Hodgkins lymphoma,VINBLASTINE,2,Recruiting,TUBB,9
central nervous system cancer,VINCRISTINE,2,Completed,TUBB,9
gastric carcinoma,DOCETAXEL,2,Unknown status,TUBB,9
breast carcinoma,DOCETAXEL,4,n/a,TUBB,9
lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,8
peritoneal neoplasm,DOCETAXEL,2,Completed,TUBB,8
neoplasm,IXABEPILONE,1,Completed,TUBB,8
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,1,"Active, not recruiting",TUBB,8
breast carcinoma,VINORELBINE,1,Completed,TUBB,8
ovarian carcinoma,PACLITAXEL,2,Unknown status,TUBB,8
breast carcinoma,PACLITAXEL,1,Unknown status,TUBB,8
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,8
lymphoma,VINCRISTINE,2,Terminated,TUBB,8
bladder carcinoma,PACLITAXEL,2,Completed,TUBB,8
breast carcinoma,TRASTUZUMAB EMTANSINE,2,"Active, not recruiting",TUBB,8
ovarian carcinoma,DOCETAXEL,1,Completed,TUBB,8
lung carcinoma,PACLITAXEL,3,Unknown status,TUBB,8
esophageal carcinoma,PACLITAXEL,2,Recruiting,TUBB,8
cancer,PACLITAXEL,1,"Active, not recruiting",TUBB,8
lung carcinoma,VINORELBINE,3,Completed,TUBB,8
cancer,PACLITAXEL,1,Terminated,TUBB,7
gastric carcinoma,DOCETAXEL,1,Completed,TUBB,7
male breast carcinoma,PACLITAXEL,1,Completed,TUBB,7
lung carcinoma,DOCETAXEL,3,Completed,TUBB,7
cancer,PACLITAXEL,1,Recruiting,TUBB,7
breast neoplasm,PACLITAXEL,1,Completed,TUBB,7
lung carcinoma,DOCETAXEL,1,Completed,TUBB,7
Fallopian Tube Carcinoma,PACLITAXEL,3,Completed,TUBB,7
Fallopian Tube Carcinoma,PACLITAXEL,1,Recruiting,TUBB,7
ovarian carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,7
leukemia,VINCRISTINE,2,Recruiting,TUBB,7
esophageal carcinoma,DOCETAXEL,2,Completed,TUBB,7
pancreatic carcinoma,PACLITAXEL,2,Completed,TUBB,7
esophageal carcinoma,PACLITAXEL,3,Recruiting,TUBB,7
acute lymphoblastic leukemia,VINCRISTINE,3,Recruiting,TUBB,7
breast carcinoma,VINORELBINE,2,Unknown status,TUBB,7
acute lymphoblastic leukemia,VINCRISTINE,1,Completed,TUBB,7
multiple myeloma,VINCRISTINE,3,Completed,TUBB,7
breast carcinoma,DOCETAXEL,3,Recruiting,TUBB,7
breast carcinoma,DOCETAXEL,1,Terminated,TUBB,7
prostate adenocarcinoma,DOCETAXEL,1,Completed,TUBB,7
neoplasm,VINORELBINE,1,Completed,TUBB,7
diffuse large B-cell lymphoma,VINCRISTINE,1,Completed,TUBB,7
gastric carcinoma,PACLITAXEL,2,Unknown status,TUBB,7
diffuse large B-cell lymphoma,VINCRISTINE,3,Recruiting,TUBB,7
head and neck malignant neoplasia,PACLITAXEL,1,Completed,TUBB,7
esophageal carcinoma,PACLITAXEL,2,Unknown status,TUBB,7
prostate adenocarcinoma,DOCETAXEL,2,Terminated,TUBB,7
lymphoma,VINBLASTINE,3,Completed,TUBB,7
prostate carcinoma,DOCETAXEL,1,Recruiting,TUBB,6
diffuse large B-cell lymphoma,VINCRISTINE,1,Recruiting,TUBB,6
head and neck malignant neoplasia,DOCETAXEL,1,Completed,TUBB,6
gastric carcinoma,PACLITAXEL,2,Completed,TUBB,6
breast carcinoma,VINORELBINE,1,Terminated,TUBB,6
non-Hodgkins lymphoma,VINCRISTINE,2,Terminated,TUBB,6
pancreatic carcinoma,PACLITAXEL,2,Unknown status,TUBB,6
transitional cell carcinoma of kidney,PACLITAXEL,2,Completed,TUBB,6
breast carcinoma,VINORELBINE,3,Completed,TUBB,6
Fallopian Tube Carcinoma,DOCETAXEL,1,Completed,TUBB,6
peritoneal neoplasm,DOCETAXEL,1,Completed,TUBB,6
pancreatic carcinoma,PACLITAXEL,1,Terminated,TUBB,6
neoplasm,DOCETAXEL,1,Terminated,TUBB,6
esophageal carcinoma,DOCETAXEL,1,Completed,TUBB,6
breast carcinoma,DOCETAXEL,4,Completed,TUBB,6
prostate carcinoma,CABAZITAXEL,2,Recruiting,TUBB,6
neoplasm,CABAZITAXEL,1,Completed,TUBB,6
non-small cell lung carcinoma,VINORELBINE,1,Completed,TUBB,6
ovarian carcinoma,DOCETAXEL,2,Terminated,TUBB,6
breast carcinoma,DOCETAXEL,2,Withdrawn,TUBB,6
bladder carcinoma,PACLITAXEL,1,Completed,TUBB,6
peritoneal neoplasm,PACLITAXEL,1,Recruiting,TUBB,6
lung carcinoma,PACLITAXEL,2,Terminated,TUBB,6
prostate carcinoma,DOCETAXEL,3,Terminated,TUBB,6
non-small cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB,6
endometrial neoplasm,PACLITAXEL,2,Completed,TUBB,6
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Recruiting,TUBB,6
diffuse large B-cell lymphoma,VINCRISTINE,2,Recruiting,TUBB,6
multiple myeloma,VINCRISTINE,2,Completed,TUBB,6
pancreatic adenocarcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,6
neoplasm,PACLITAXEL,2,Completed,TUBB,6
head and neck malignant neoplasia,DOCETAXEL,2,"Active, not recruiting",TUBB,6
prostate carcinoma,DOCETAXEL,2,Withdrawn,TUBB,6
stomach neoplasm,DOCETAXEL,2,Unknown status,TUBB,6
stomach neoplasm,DOCETAXEL,2,Completed,TUBB,6
esophageal carcinoma,PACLITAXEL,1,Completed,TUBB,6
ovarian carcinoma,PACLITAXEL,1,Terminated,TUBB,6
non-small cell lung carcinoma,VINORELBINE,3,Recruiting,TUBB,6
neoplasm,PACLITAXEL,1,Terminated,TUBB,6
non-small cell lung carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,6
peritoneal neoplasm,PACLITAXEL,1,"Active, not recruiting",TUBB,6
breast carcinoma,VINORELBINE,2,Recruiting,TUBB,6
breast carcinoma,ERIBULIN,2,Terminated,TUBB,5
prostate carcinoma,PACLITAXEL,1,Completed,TUBB,5
prostate carcinoma,DOCETAXEL,1,Unknown status,TUBB,5
breast carcinoma,IXABEPILONE,1,Completed,TUBB,5
gastric carcinoma,DOCETAXEL,3,Recruiting,TUBB,5
breast carcinoma,ERIBULIN,1,"Active, not recruiting",TUBB,5
acute lymphoblastic leukemia,VINCRISTINE,4,Unknown status,TUBB,5
gastric carcinoma,PACLITAXEL,2,Recruiting,TUBB,5
bladder carcinoma,DOCETAXEL,2,Completed,TUBB,5
sarcoma,VINCRISTINE,2,Completed,TUBB,5
sarcoma,DOCETAXEL,2,Completed,TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,"Active, not recruiting",TUBB,5
small cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,5
head and neck malignant neoplasia,DOCETAXEL,2,Unknown status,TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Completed,TUBB,5
sarcoma,PACLITAXEL,2,Completed,TUBB,5
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB,5
breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,5
head and neck malignant neoplasia,PACLITAXEL,2,Unknown status,TUBB,5
breast carcinoma,DOCETAXEL,3,Terminated,TUBB,5
breast neoplasm,DOCETAXEL,2,Terminated,TUBB,5
squamous cell carcinoma,DOCETAXEL,2,Completed,TUBB,5
neoplasm,PACLITAXEL,1,"Active, not recruiting",TUBB,5
Fallopian Tube Carcinoma,PACLITAXEL,2,Terminated,TUBB,5
neoplasm,PACLITAXEL,1,Unknown status,TUBB,5
pancreatic adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,5
lung carcinoma,DOCETAXEL,2,Terminated,TUBB,5
peritoneal neoplasm,PACLITAXEL,2,Recruiting,TUBB,5
lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,5
lymphoma,VINCRISTINE,3,Terminated,TUBB,5
breast neoplasm,PACLITAXEL,2,Recruiting,TUBB,5
breast neoplasm,PACLITAXEL,3,"Active, not recruiting",TUBB,5
pancreatic adenocarcinoma,PACLITAXEL,2,Completed,TUBB,5
Mantle cell lymphoma,VINCRISTINE,2,Completed,TUBB,5
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,1,Completed,TUBB,5
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,1,Recruiting,TUBB,5
breast neoplasm,VINORELBINE,2,Completed,TUBB,5
neuroblastoma,VINCRISTINE,3,Unknown status,TUBB,5
neuroblastoma,VINCRISTINE,3,Completed,TUBB,5
Hodgkins lymphoma,VINBLASTINE,2,Completed,TUBB,5
Hodgkins lymphoma,VINBLASTINE,3,Completed,TUBB,5
neuroblastoma,VINCRISTINE,1,Completed,TUBB,5
lymphoma,VINBLASTINE,3,"Active, not recruiting",TUBB,5
diffuse large B-cell lymphoma,VINCRISTINE,3,Completed,TUBB,5
lymphoma,PACLITAXEL,2,Completed,TUBB,5
lymphoma,PACLITAXEL,1,Completed,TUBB,5
diffuse large B-cell lymphoma,VINCRISTINE,2,Terminated,TUBB,5
cancer,IXABEPILONE,1,Completed,TUBB,5
Fallopian Tube Carcinoma,PACLITAXEL,2,Recruiting,TUBB,5
diffuse large B-cell lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,5
pancreatic carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,5
breast carcinoma,VINORELBINE,3,Recruiting,TUBB,5
acute lymphoblastic leukemia,VINCRISTINE,1,Recruiting,TUBB,5
pancreatic carcinoma,PACLITAXEL,2,Terminated,TUBB,5
neoplasm,DOCETAXEL,1,Recruiting,TUBB,5
cervical carcinoma,PACLITAXEL,2,Completed,TUBB,5
ovarian carcinoma,PACLITAXEL,3,Recruiting,TUBB,5
leukemia,VINCRISTINE,3,"Active, not recruiting",TUBB,5
non-small cell lung carcinoma,DOCETAXEL,1,Recruiting,TUBB,5
cervical carcinoma,PACLITAXEL,3,Recruiting,TUBB,5
ovarian carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,5
nasopharyngeal neoplasm,DOCETAXEL,2,Unknown status,TUBB,5
Hodgkins lymphoma,VINBLASTINE,2,"Active, not recruiting",TUBB,4
central nervous system cancer,VINCRISTINE,1,Completed,TUBB,4
gastric carcinoma,PACLITAXEL,1,Unknown status,TUBB,4
gastric carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,4
pancreatic adenocarcinoma,PACLITAXEL,1,Completed,TUBB,4
cutaneous melanoma,PACLITAXEL,2,Completed,TUBB,4
esophageal squamous cell carcinoma,PACLITAXEL,2,Recruiting,TUBB,4
ovarian carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,4
Hodgkins lymphoma,VINBLASTINE,2,Unknown status,TUBB,4
prostate carcinoma,DOCETAXEL,2,Unknown status,TUBB,4
breast carcinoma,PACLITAXEL,2,Withdrawn,TUBB,4
non-small cell lung carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB,4
breast carcinoma,ERIBULIN,3,Recruiting,TUBB,4
nasopharyngeal neoplasm,DOCETAXEL,2,Completed,TUBB,4
non-small cell lung carcinoma,VINORELBINE,2,Terminated,TUBB,4
breast carcinoma,PACLITAXEL,3,Terminated,TUBB,4
Hodgkins lymphoma,VINCRISTINE,2,Recruiting,TUBB,4
lymphoma,VINCRISTINE,2,Recruiting,TUBB,4
nasopharyngeal neoplasm,DOCETAXEL,3,Unknown status,TUBB,4
cervical carcinoma,PACLITAXEL,3,Unknown status,TUBB,4
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,2,"Active, not recruiting",TUBB,4
Fallopian Tube Carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,4
Fallopian Tube Carcinoma,DOCETAXEL,2,Completed,TUBB,4
central nervous system cancer,VINCRISTINE,3,Completed,TUBB,4
Fallopian Tube Carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,4
breast carcinoma,IXABEPILONE,3,Completed,TUBB,4
breast carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,4
neoplasm,PACLITAXEL,3,Completed,TUBB,4
central nervous system cancer,VINCRISTINE,3,Unknown status,TUBB,4
esophageal carcinoma,PACLITAXEL,2,Terminated,TUBB,4
peritoneal neoplasm,PACLITAXEL,3,"Active, not recruiting",TUBB,4
nasopharyngeal neoplasm,PACLITAXEL,3,Recruiting,TUBB,4
pancreatic carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,4
gastric carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,4
neoplasm,VINCRISTINE,1,Completed,TUBB,4
gastric carcinoma,DOCETAXEL,2,Recruiting,TUBB,4
pancreatic ductal adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,4
gastric carcinoma,DOCETAXEL,2,Terminated,TUBB,4
upper aerodigestive tract neoplasm,DOCETAXEL,2,Completed,TUBB,4
prostate carcinoma,VINORELBINE,2,Completed,TUBB,4
pancreatic carcinoma,PACLITAXEL,1,Unknown status,TUBB,4
breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB,4
peritoneal neoplasm,PACLITAXEL,2,Unknown status,TUBB,4
bladder carcinoma,VINBLASTINE,2,Completed,TUBB,4
acute lymphoblastic leukemia,VINCRISTINE,1,Terminated,TUBB,4
lung carcinoma,PACLITAXEL POLIGLUMEX,3,Unknown status,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,4
lung carcinoma,PACLITAXEL,1,Terminated,TUBB,4
lung carcinoma,DOCETAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB,4
endometrial neoplasm,PACLITAXEL,2,Recruiting,TUBB,4
cancer,ERIBULIN,1,Completed,TUBB,4
head and neck squamous cell carcinoma,DOCETAXEL,2,Completed,TUBB,4
head and neck squamous cell carcinoma,DOCETAXEL,2,Recruiting,TUBB,4
lung carcinoma,DOCETAXEL,1,Terminated,TUBB,4
ovarian carcinoma,PACLITAXEL,3,Unknown status,TUBB,4
ovarian carcinoma,PACLITAXEL,1,Unknown status,TUBB,4
prostate carcinoma,CABAZITAXEL,3,Completed,TUBB,4
non-Hodgkins lymphoma,VINCRISTINE,2,Completed,TUBB,4
non-Hodgkins lymphoma,VINCRISTINE,3,"Active, not recruiting",TUBB,4
prostate carcinoma,CABAZITAXEL,2,Completed,TUBB,4
breast carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,4
squamous cell carcinoma,PACLITAXEL,2,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Unknown status,TUBB,4
ovarian carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,3,Unknown status,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,4
non-small cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,4
non-small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB,4
breast neoplasm,PACLITAXEL,2,Withdrawn,TUBB,4
breast carcinoma,TRASTUZUMAB EMTANSINE,3,"Active, not recruiting",TUBB,4
cervical carcinoma,PACLITAXEL,2,Unknown status,TUBB,4
lung carcinoma,VINORELBINE,2,Unknown status,TUBB,4
gout,COLCHICINE,4,Completed,TUBB,4
sarcoma,DOCETAXEL,1,Completed,TUBB,4
"Lymphoma, AIDS-Related",VINCRISTINE,2,Completed,TUBB,4
gout,COLCHICINE,2,Completed,TUBB,4
lung carcinoma,VINORELBINE,3,Unknown status,TUBB,4
prostate adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB,4
prostate carcinoma,DOCETAXEL,1,Terminated,TUBB,4
ovarian neoplasm,PACLITAXEL,2,Completed,TUBB,4
diffuse large B-cell lymphoma,VINCRISTINE,2,Unknown status,TUBB,4
prostate adenocarcinoma,DOCETAXEL,3,Completed,TUBB,4
Mantle cell lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,4
Hodgkins lymphoma,VINORELBINE,2,Completed,TUBB,4
non-small cell lung carcinoma,PACLITAXEL,3,Unknown status,TUBB,4
breast neoplasm,DOCETAXEL,2,Unknown status,TUBB,3
breast carcinoma,PACLITAXEL,4,Unknown status,TUBB,3
prostate carcinoma,CABAZITAXEL,1,Completed,TUBB,3
breast carcinoma,VINFLUNINE,3,Completed,TUBB,3
cervical carcinoma,PACLITAXEL,1,Completed,TUBB,3
cervical carcinoma,PACLITAXEL,2,Recruiting,TUBB,3
diffuse large B-cell lymphoma,VINCRISTINE,3,"Active, not recruiting",TUBB,3
breast neoplasm,DOCETAXEL,1,Completed,TUBB,3
cancer,PACLITAXEL,1,Unknown status,TUBB,3
pancreatic neoplasm,PACLITAXEL,2,Completed,TUBB,3
breast carcinoma,IXABEPILONE,2,Terminated,TUBB,3
prostate carcinoma,CABAZITAXEL,2,Terminated,TUBB,3
prostate carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,3
diffuse large B-cell lymphoma,VINCRISTINE,1,Withdrawn,TUBB,3
ovarian cystadenocarcinoma,PACLITAXEL,1,Completed,TUBB,3
endometrioid carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,3
peritoneal neoplasm,PACLITAXEL,1,Terminated,TUBB,3
prostate carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,3
breast carcinoma,PACLITAXEL,1,Withdrawn,TUBB,3
breast neoplasm,PACLITAXEL,2,Terminated,TUBB,3
breast neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,3
endometrial neoplasm,DOCETAXEL,1,Completed,TUBB,3
peritoneal neoplasm,PACLITAXEL,3,Recruiting,TUBB,3
ovarian carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,3
ovarian mucinous cystadenocarcinoma,PACLITAXEL,1,Completed,TUBB,3
carcinoma,PACLITAXEL,2,Completed,TUBB,3
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Completed,TUBB,3
central nervous system cancer,VINCRISTINE,2,Unknown status,TUBB,3
pancreatic carcinoma,DOCETAXEL,2,Terminated,TUBB,3
esophageal carcinoma,PACLITAXEL,1,Recruiting,TUBB,3
ovarian serous cystadenocarcinoma,PACLITAXEL,1,Completed,TUBB,3
prostate carcinoma,CABAZITAXEL,4,Completed,TUBB,3
breast neoplasm,PACLITAXEL,1,Recruiting,TUBB,3
endometrial neoplasm,PACLITAXEL,3,Recruiting,TUBB,3
prostate carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,3
ovarian neoplasm,DOCETAXEL,2,Completed,TUBB,3
endometrial neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,3
endometrioid carcinoma,PACLITAXEL,1,Completed,TUBB,3
bladder carcinoma,PACLITAXEL,2,Terminated,TUBB,3
prostate carcinoma,DOCETAXEL,3,Recruiting,TUBB,3
non-Hodgkins lymphoma,VINCRISTINE,3,Completed,TUBB,3
lymphoid leukemia,VINCRISTINE,2,Recruiting,TUBB,3
transitional cell carcinoma of kidney,PACLITAXEL,1,Completed,TUBB,3
Malignant Ovarian Brenner Tumor,PACLITAXEL,1,Completed,TUBB,3
Malignant Ovarian Brenner Tumor,PACLITAXEL,3,"Active, not recruiting",TUBB,3
lung carcinoma,VINORELBINE,1,Completed,TUBB,3
Mantle cell lymphoma,VINCRISTINE,1,Completed,TUBB,3
lung carcinoma,VINBLASTINE,3,Unknown status,TUBB,3
lung carcinoma,VINBLASTINE,3,Completed,TUBB,3
prostate carcinoma,DOCETAXEL,3,Unknown status,TUBB,3
lung carcinoma,DOCETAXEL,3,Terminated,TUBB,3
non-Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,3
non-Hodgkins lymphoma,VINCRISTINE,1,Completed,TUBB,3
leukemia,VINCRISTINE,3,Unknown status,TUBB,3
triple-negative breast cancer,PACLITAXEL,2,"Active, not recruiting",TUBB,3
leukemia,VINCRISTINE,2,Unknown status,TUBB,3
squamous cell lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,3
squamous cell lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,3
leukemia,VINCRISTINE,1,Completed,TUBB,3
non-Hodgkins lymphoma,VINORELBINE,2,Completed,TUBB,3
non-small cell lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,3
squamous cell carcinoma,PACLITAXEL,2,Recruiting,TUBB,3
squamous cell carcinoma,PACLITAXEL,2,Completed,TUBB,3
acute lymphoblastic leukemia,VINCRISTINE,2,"Active, not recruiting",TUBB,3
acute lymphoblastic leukemia,VINCRISTINE,3,Completed,TUBB,3
acute lymphoblastic leukemia,VINCRISTINE,4,Recruiting,TUBB,3
non-small cell lung carcinoma,ERIBULIN,2,Completed,TUBB,3
neoplasm of mature B-cells,VINCRISTINE,3,Terminated,TUBB,3
neoplasm of mature B-cells,VINCRISTINE,3,"Active, not recruiting",TUBB,3
head and neck squamous cell carcinoma,DOCETAXEL,2,Terminated,TUBB,3
male breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,3
nasopharyngeal neoplasm,DOCETAXEL,3,Not yet recruiting,TUBB,3
nasopharyngeal neoplasm,DOCETAXEL,3,Recruiting,TUBB,3
uterine neoplasm,PACLITAXEL,2,Completed,TUBB,3
metastatic prostate cancer,DOCETAXEL,2,Completed,TUBB,3
neoplasm,INDIBULIN,1,Unknown status,TUBB,3
neoplasm,IXABEPILONE,1,Terminated,TUBB,3
Fallopian Tube Carcinoma,PACLITAXEL,2,Unknown status,TUBB,3
Fallopian Tube Carcinoma,PACLITAXEL,3,Recruiting,TUBB,3
melanoma,PACLITAXEL,1,Completed,TUBB,3
neoplasm,PACLITAXEL,1,Withdrawn,TUBB,3
urethral neoplasm,PACLITAXEL,2,Completed,TUBB,3
medulloblastoma,VINCRISTINE,3,Completed,TUBB,3
lymphoma,VINORELBINE,2,Completed,TUBB,3
Hodgkins lymphoma,VINCRISTINE,3,Recruiting,TUBB,3
lymphoma,VINCRISTINE,3,Recruiting,TUBB,3
lymphoma,VINCRISTINE,2,Withdrawn,TUBB,3
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,2,Not yet recruiting,TUBB,3
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,3,"Active, not recruiting",TUBB,3
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,3,Recruiting,TUBB,3
unspecified peripheral T-cell lymphoma,VINCRISTINE,2,Completed,TUBB,3
lymphoma,VINCRISTINE,1,Unknown status,TUBB,3
Hodgkins lymphoma,VINBLASTINE,1,Completed,TUBB,3
lymphoma,VINBLASTINE,2,Unknown status,TUBB,3
neoplasm of mature B-cells,VINCRISTINE,1,Recruiting,TUBB,3
neoplasm of mature B-cells,VINCRISTINE,2,Recruiting,TUBB,3
Hodgkins lymphoma,VINCRISTINE,3,Completed,TUBB,3
small cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,3
lung carcinoma,PACLITAXEL,3,Terminated,TUBB,3
breast carcinoma,DOCETAXEL,4,Recruiting,TUBB,3
bladder carcinoma,VINBLASTINE,2,Terminated,TUBB,3
breast carcinoma,ERIBULIN,2,Recruiting,TUBB,3
esophageal squamous cell carcinoma,PACLITAXEL,3,Recruiting,TUBB,3
breast carcinoma,ERIBULIN,1,Completed,TUBB,3
bladder carcinoma,PACLITAXEL,3,Completed,TUBB,3
breast carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,3
gastric adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,3
non-small cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB,3
head and neck malignant neoplasia,DOCETAXEL,3,Terminated,TUBB,3
gastric carcinoma,DOCETAXEL,3,Completed,TUBB,3
non-small cell lung carcinoma,VINORELBINE,4,Completed,TUBB,3
brain neoplasm,VINCRISTINE,1,Completed,TUBB,3
gastric carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,3
gastric carcinoma,PACLITAXEL,1,Completed,TUBB,3
gastric carcinoma,PACLITAXEL,2,Terminated,TUBB,3
head and neck malignant neoplasia,DOCETAXEL,1,Recruiting,TUBB,3
bladder transitional cell carcinoma,PACLITAXEL,2,Completed,TUBB,3
breast carcinoma,ERIBULIN,3,Completed,TUBB,3
sarcoma,VINCRISTINE,3,Unknown status,TUBB,3
metastatic prostate cancer,DOCETAXEL,2,Recruiting,TUBB,2
pancreatic ductal adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
pancreatic neoplasm,PACLITAXEL,1,Recruiting,TUBB,2
nasopharyngeal neoplasm,PACLITAXEL,1,Completed,TUBB,2
cutaneous melanoma,VINBLASTINE,3,Completed,TUBB,2
gastric carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,2
gastric carcinoma,DOCETAXEL,1,Unknown status,TUBB,2
gastric adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,2
esophageal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
pancreatic ductal adenocarcinoma,PACLITAXEL,2,Terminated,TUBB,2
gastric adenocarcinoma,DOCETAXEL,2,Unknown status,TUBB,2
gastric adenocarcinoma,DOCETAXEL,2,Terminated,TUBB,2
lymphoma,VINORELBINE,1,Completed,TUBB,2
childhood B acute lymphoblastic leukemia,VINCRISTINE,3,Completed,TUBB,2
pancreatic adenocarcinoma,DOCETAXEL,2,Completed,TUBB,2
diffuse large B-cell lymphoma,BRENTUXIMAB VEDOTIN,1,"Active, not recruiting",TUBB,2
diffuse large B-cell lymphoma,BRENTUXIMAB VEDOTIN,2,Terminated,TUBB,2
multiple myeloma,PACLITAXEL,2,Completed,TUBB,2
diffuse large B-cell lymphoma,VINCRISTINE,1,"Active, not recruiting",TUBB,2
lymphoma,VINBLASTINE,3,Unknown status,TUBB,2
lymphoma,VINBLASTINE,3,Terminated,TUBB,2
esophageal squamous cell carcinoma,DOCETAXEL,3,Recruiting,TUBB,2
lymphoma,VINBLASTINE,2,"Active, not recruiting",TUBB,2
neoplasm,VINORELBINE,1,Unknown status,TUBB,2
lymphoma,PACLITAXEL,1,Unknown status,TUBB,2
non-small cell lung carcinoma,VINORELBINE,3,Unknown status,TUBB,2
neoplasm of mature B-cells,VINCRISTINE,2,Completed,TUBB,2
esophageal squamous cell carcinoma,DOCETAXEL,2,Recruiting,TUBB,2
nasopharyngeal neoplasm,DOCETAXEL,3,"Active, not recruiting",TUBB,2
gastric carcinoma,PACLITAXEL,1,Recruiting,TUBB,2
multiple myeloma,VINCRISTINE,3,Unknown status,TUBB,2
neoplasm,TRASTUZUMAB EMTANSINE,4,n/a,TUBB,2
male breast carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
metastatic prostate cancer,DOCETAXEL,2,Not yet recruiting,TUBB,2
pancreatic carcinoma,PACLITAXEL,3,Recruiting,TUBB,2
esophageal squamous cell carcinoma,PACLITAXEL,1,Completed,TUBB,2
chronic lymphocytic leukemia,VINCRISTINE,3,Completed,TUBB,2
metastatic prostate cancer,DOCETAXEL,1,Completed,TUBB,2
metastatic prostate cancer,CABAZITAXEL,1,Recruiting,TUBB,2
nasopharyngeal neoplasm,PACLITAXEL,2,Recruiting,TUBB,2
metastatic melanoma,PACLITAXEL,2,Completed,TUBB,2
neoplasm,DOCETAXEL,2,"Active, not recruiting",TUBB,2
neoplasm,DOCETAXEL,2,Completed,TUBB,2
mesothelioma,VINORELBINE,2,Unknown status,TUBB,2
neoplasm,ERIBULIN,1,Recruiting,TUBB,2
cholangiocarcinoma,PACLITAXEL,2,Completed,TUBB,2
neoplasm,FOSBRETABULIN,1,Completed,TUBB,2
cognitive impairment,DAVUNETIDE,2,Completed,TUBB,2
esophageal squamous cell carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,2
melanoma,PACLITAXEL,3,Terminated,TUBB,2
medulloblastoma,VINCRISTINE,2,Recruiting,TUBB,2
melanoma,PACLITAXEL,2,Terminated,TUBB,2
melanoma,PACLITAXEL,2,Recruiting,TUBB,2
pancreatic carcinoma,IXABEPILONE,2,Completed,TUBB,2
pancreatic carcinoma,DOCETAXEL,2,Unknown status,TUBB,2
pancreatic ductal adenocarcinoma,PACLITAXEL,1,Completed,TUBB,2
neoplasm,PACLITAXEL,1,Not yet recruiting,TUBB,2
non-small cell lung carcinoma,VINORELBINE,3,Terminated,TUBB,2
esophageal carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,2
melanoma,DOCETAXEL,2,Completed,TUBB,2
pancreatic carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,2
gastric adenocarcinoma,DOCETAXEL,1,Unknown status,TUBB,2
pancreatic adenocarcinoma,PACLITAXEL,4,Recruiting,TUBB,2
gastric adenocarcinoma,DOCETAXEL,2,Completed,TUBB,2
pancreatic adenocarcinoma,PACLITAXEL,2,Terminated,TUBB,2
head and neck squamous cell carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,2
neoplasm of mature B-cells,VINCRISTINE,3,Recruiting,TUBB,2
ovarian serous adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
non-Hodgkins lymphoma,VINCRISTINE,3,Recruiting,TUBB,2
non-small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB,2
head and neck malignant neoplasia,PACLITAXEL,1,Unknown status,TUBB,2
leukemia,VINCRISTINE,2,"Active, not recruiting",TUBB,2
head and neck malignant neoplasia,DOCETAXEL,3,Completed,TUBB,2
head and neck malignant neoplasia,DOCETAXEL,2,Terminated,TUBB,2
leukemia,VINCRISTINE,2,Terminated,TUBB,2
head and neck malignant neoplasia,DOCETAXEL,2,Recruiting,TUBB,2
gout,COLCHICINE,3,Completed,TUBB,2
endometrial neoplasm,PACLITAXEL,3,Terminated,TUBB,2
lung adenocarcinoma,PACLITAXEL,1,Terminated,TUBB,2
ovarian carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,2
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,2
lung adenocarcinoma,PACLITAXEL,2,Completed,TUBB,2
ovarian carcinoma,PACLITAXEL,3,Terminated,TUBB,2
lung adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,2
lung adenocarcinoma,PACLITAXEL,2,Terminated,TUBB,2
head and neck malignant neoplasia,PACLITAXEL,2,"Active, not recruiting",TUBB,2
non-small cell lung carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB,2
head and neck malignant neoplasia,PACLITAXEL,2,Terminated,TUBB,2
laryngeal neoplasm,DOCETAXEL,2,Terminated,TUBB,2
non-small cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,2
head and neck squamous cell carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,2
non-small cell lung carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,2
esophageal carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,2
non-small cell lung carcinoma,IXABEPILONE,2,Completed,TUBB,2
non-small cell lung carcinoma,IXABEPILONE,1,Completed,TUBB,2
head and neck squamous cell carcinoma,DOCETAXEL,1,Completed,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB,2
head and neck squamous cell carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,2
esophageal carcinoma,DOCETAXEL,2,Terminated,TUBB,2
non-small cell lung carcinoma,DOCETAXEL,4,Completed,TUBB,2
inflammatory breast carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,2
inflammatory breast carcinoma,PACLITAXEL,2,Recruiting,TUBB,2
esophageal carcinoma,PACLITAXEL,1,Unknown status,TUBB,2
head and neck malignant neoplasia,PACLITAXEL,3,Completed,TUBB,2
non-Hodgkins lymphoma,VINCRISTINE,1,"Active, not recruiting",TUBB,2
lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,2
neoplasm of mature B-cells,VINCRISTINE,3,Completed,TUBB,2
ovarian neoplasm,SAGOPILONE,2,Completed,TUBB,2
lung carcinoma,VINORELBINE,3,Recruiting,TUBB,2
neuroblastoma,VINCRISTINE,2,Unknown status,TUBB,2
gastric carcinoma,PACLITAXEL,3,Unknown status,TUBB,2
lymphoid leukemia,VINCRISTINE,1,Completed,TUBB,2
ovarian neoplasm,PACLITAXEL,1,Completed,TUBB,2
neuroblastoma,VINCRISTINE,2,Recruiting,TUBB,2
diffuse large B-cell lymphoma,VINCRISTINE,4,Recruiting,TUBB,2
gastric carcinoma,PACLITAXEL,3,Recruiting,TUBB,2
endometrial neoplasm,PACLITAXEL,3,Completed,TUBB,2
diffuse large B-cell lymphoma,VINCRISTINE,3,Unknown status,TUBB,2
lymphoid leukemia,VINCRISTINE,2,Completed,TUBB,2
diffuse large B-cell lymphoma,VINCRISTINE,3,Terminated,TUBB,2
gastric carcinoma,PACLITAXEL,3,Completed,TUBB,2
diffuse large B-cell lymphoma,VINCRISTINE,3,Not yet recruiting,TUBB,2
neoplasm of mature B-cells,VINCRISTINE,3,Unknown status,TUBB,2
head and neck squamous cell carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,2
ovarian mucinous adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
non-small cell lung carcinoma,VINORELBINE,2,Not yet recruiting,TUBB,2
endometrial neoplasm,DOCETAXEL,2,Completed,TUBB,2
ovarian cystadenocarcinoma,PACLITAXEL,2,Completed,TUBB,2
endometrial neoplasm,PACLITAXEL,2,Unknown status,TUBB,2
glioblastoma multiforme,VERUBULIN,2,Completed,TUBB,2
lung carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,2
cervical carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,2
nodular sclerosis Hodgkin lymphoma,VINORELBINE,2,Completed,TUBB,2
lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,2
lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,2
lung carcinoma,PACLITAXEL,2,Withdrawn,TUBB,2
germ cell tumor,PACLITAXEL,2,Recruiting,TUBB,2
lung carcinoma,PACLITAXEL,3,Withdrawn,TUBB,2
lung carcinoma,VINBLASTINE,1,Unknown status,TUBB,2
endometrial neoplasm,PACLITAXEL,1,Completed,TUBB,2
endometrial neoplasm,MIRVETUXIMAB SORAVTANSINE,2,Not yet recruiting,TUBB,2
germ cell tumor,PACLITAXEL,2,"Active, not recruiting",TUBB,2
lung carcinoma,VINCRISTINE,3,Completed,TUBB,2
leukemia,PACLITAXEL,1,Completed,TUBB,2
central nervous system cancer,VINORELBINE,2,Completed,TUBB,2
cervical carcinoma,PACLITAXEL,2,Terminated,TUBB,2
prostate carcinoma,IXABEPILONE,2,Completed,TUBB,2
breast carcinoma,PACLITAXEL,4,Completed,TUBB,2
Hodgkins lymphoma,VINBLASTINE,1,Recruiting,TUBB,2
breast carcinoma,PACLITAXEL,2,Suspended,TUBB,2
breast carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB,2
breast carcinoma,IXABEPILONE,3,"Active, not recruiting",TUBB,2
Hodgkins lymphoma,VINBLASTINE,2,Terminated,TUBB,2
breast carcinoma,IXABEPILONE,1,Terminated,TUBB,2
Hodgkins lymphoma,VINBLASTINE,3,"Active, not recruiting",TUBB,2
Hodgkins lymphoma,VINBLASTINE,4,Recruiting,TUBB,2
Hodgkins lymphoma,VINBLASTINE,4,Unknown status,TUBB,2
breast carcinoma,ERIBULIN,2,Not yet recruiting,TUBB,2
prostate carcinoma,VINBLASTINE,3,Completed,TUBB,2
Hodgkins lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,2
triple-negative breast cancer,PACLITAXEL,3,Recruiting,TUBB,2
breast carcinoma,ERIBULIN,1,Recruiting,TUBB,2
breast carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB,2
prostate carcinoma,PACLITAXEL,2,Unknown status,TUBB,2
prostate carcinoma,PACLITAXEL,2,Withdrawn,TUBB,2
breast carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,2
prostate carcinoma,PACLITAXEL,3,Completed,TUBB,2
Hodgkins lymphoma,VINCRISTINE,3,"Active, not recruiting",TUBB,2
triple-negative breast cancer,PACLITAXEL,2,Completed,TUBB,2
breast carcinoma,PACLITAXEL,4,Recruiting,TUBB,2
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,2
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,2
Hodgkins lymphoma,PACLITAXEL,1,Terminated,TUBB,2
breast neoplasm,VINORELBINE,2,Recruiting,TUBB,2
prostate adenocarcinoma,DOCETAXEL,2,Unknown status,TUBB,2
prostate adenocarcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,2
breast neoplasm,SAGOPILONE,2,Completed,TUBB,2
breast neoplasm,PACLITAXEL,3,Recruiting,TUBB,2
breast neoplasm,PACLITAXEL,3,Completed,TUBB,2
prostate adenocarcinoma,DOCETAXEL,3,Terminated,TUBB,2
breast neoplasm,PACLITAXEL,1,"Active, not recruiting",TUBB,2
prostate adenocarcinoma,IXABEPILONE,2,Completed,TUBB,2
upper aerodigestive tract neoplasm,DOCETAXEL,1,Completed,TUBB,2
prostate carcinoma,CABAZITAXEL,1,Recruiting,TUBB,2
breast neoplasm,DOCETAXEL,3,Recruiting,TUBB,2
breast neoplasm,DOCETAXEL,2,Withdrawn,TUBB,2
breast neoplasm,DOCETAXEL,2,Recruiting,TUBB,2
breast neoplasm,DOCETAXEL,1,"Active, not recruiting",TUBB,2
breast carcinoma,VINORELBINE,4,Recruiting,TUBB,2
breast carcinoma,VINORELBINE,3,Unknown status,TUBB,2
breast carcinoma,VINORELBINE,2,Not yet recruiting,TUBB,2
breast carcinoma,VINORELBINE,1,Unknown status,TUBB,2
prostate carcinoma,CABAZITAXEL,3,Recruiting,TUBB,2
unspecified peripheral T-cell lymphoma,VINCRISTINE,2,Recruiting,TUBB,2
triple-negative breast cancer,DOCETAXEL,2,Recruiting,TUBB,2
transitional cell carcinoma of kidney,PACLITAXEL,3,Completed,TUBB,2
breast neoplasm,VINORELBINE,2,Terminated,TUBB,2
adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB,2
anaplastic large cell lymphoma,VINORELBINE,2,Recruiting,TUBB,2
Retinoblastoma,VINCRISTINE,2,Recruiting,TUBB,2
sarcoma,VINCRISTINE,2,Unknown status,TUBB,2
sarcoma,VINCRISTINE,3,Completed,TUBB,2
sarcoma,VINORELBINE,2,Completed,TUBB,2
Retinoblastoma,VINCRISTINE,3,"Active, not recruiting",TUBB,2
Retinoblastoma,VINCRISTINE,3,Completed,TUBB,2
Sinonasal Undifferentiated Carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,2
T-cell acute lymphoblastic leukemia,VINCRISTINE,1,Not yet recruiting,TUBB,2
T-cell acute lymphoblastic leukemia,VINCRISTINE,1,Recruiting,TUBB,2
acute myocardial infarction,COLCHICINE,4,Unknown status,TUBB,2
breast adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,2
soft tissue sarcoma,ERIBULIN,2,Completed,TUBB,2
acute lymphoblastic leukemia,VINCRISTINE,3,Unknown status,TUBB,2
acute lymphoblastic leukemia,VINCRISTINE,3,Terminated,TUBB,2
acute lymphoblastic leukemia,VINCRISTINE,3,"Active, not recruiting",TUBB,2
acute lymphoblastic leukemia,VINCRISTINE,2,Terminated,TUBB,2
squamous cell carcinoma,PACLITAXEL,3,Recruiting,TUBB,2
acute lymphoblastic leukemia,VINCRISTINE,1,Not yet recruiting,TUBB,2
squamous cell carcinoma,DOCETAXEL,2,Recruiting,TUBB,2
squamous cell carcinoma,DOCETAXEL,2,Unknown status,TUBB,2
squamous cell carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,2
Retinoblastoma,VINCRISTINE,2,Completed,TUBB,2
stomach neoplasm,DOCETAXEL,1,Completed,TUBB,2
sarcoma,PACLITAXEL,2,Terminated,TUBB,2
angiosarcoma,PACLITAXEL,2,Recruiting,TUBB,2
breast adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,2
bladder transitional cell carcinoma,VINFLUNINE,2,Completed,TUBB,2
Malignant epithelial tumor of ovary,PACLITAXEL,2,Recruiting,TUBB,2
renal carcinoma,VINCRISTINE,3,Completed,TUBB,2
renal carcinoma,VINCRISTINE,3,Unknown status,TUBB,2
bladder carcinoma,VINFLUNINE,3,Completed,TUBB,2
Mantle cell lymphoma,VINCRISTINE,3,Completed,TUBB,2
bladder carcinoma,VINBLASTINE,3,Completed,TUBB,2
bladder carcinoma,VINBLASTINE,2,Recruiting,TUBB,2
Mantle cell lymphoma,VINCRISTINE,3,Recruiting,TUBB,2
Mantle cell lymphoma,VINCRISTINE,3,Unknown status,TUBB,2
testicular neoplasm,PACLITAXEL,2,Completed,TUBB,2
Nephroblastoma,VINCRISTINE,3,Completed,TUBB,2
bladder carcinoma,DOCETAXEL,2,Terminated,TUBB,2
biliary tract neoplasm,PACLITAXEL,2,Recruiting,TUBB,2
Ovarian Transitional Cell Carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
biliary tract neoplasm,DOCETAXEL,2,Terminated,TUBB,2
sarcoma,DOCETAXEL,2,Unknown status,TUBB,2
sarcoma,DOCETAXEL,3,Completed,TUBB,2
Primary Peritoneal Serous Adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,2
sarcoma,PACLITAXEL,1,Recruiting,TUBB,2
ureteral neoplasm,PACLITAXEL,2,Completed,TUBB,2
breast carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB,2
urogenital neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,2
prostate adenocarcinoma,DOCETAXEL,1,Terminated,TUBB,2
prostate adenocarcinoma,CABAZITAXEL,2,"Active, not recruiting",TUBB,2
cancer,VINORELBINE,2,Completed,TUBB,2
primitive neuroectodermal tumor,VINCRISTINE,3,Completed,TUBB,2
prostate adenocarcinoma,DOCETAXEL,1,Unknown status,TUBB,2
central nervous system cancer,PACLITAXEL,2,Completed,TUBB,2
cancer,VINFLUNINE,1,Completed,TUBB,2
cervical carcinoma,DOCETAXEL,2,Completed,TUBB,2
Burkitts lymphoma,VINCRISTINE,2,Completed,TUBB,2
urothelial carcinoma,CABAZITAXEL,2,Completed,TUBB,2
Fallopian Tube Carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,2
pericarditis,COLCHICINE,3,Completed,TUBB,2
urogenital neoplasm,PACLITAXEL,2,Completed,TUBB,2
cancer,DOCETAXEL,2,Completed,TUBB,2
Fallopian Tube Carcinoma,PACLITAXEL,1,Terminated,TUBB,2
cancer,DOCETAXEL,2,Terminated,TUBB,2
peritoneal neoplasm,DOCETAXEL,2,Terminated,TUBB,2
peritoneal neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,2
central nervous system cancer,VINBLASTINE,2,Recruiting,TUBB,2
cervical carcinoma,DOCETAXEL,1,Completed,TUBB,2
urothelial carcinoma,DOCETAXEL,2,Withdrawn,TUBB,2
cervical carcinoma,PACLITAXEL,1,Unknown status,TUBB,2
central nervous system cancer,VINCRISTINE,3,Recruiting,TUBB,2
breast neoplasm,VINORELBINE,3,Completed,TUBB,2
cancer,PACLITAXEL,2,Terminated,TUBB,2
uterine neoplasm,PACLITAXEL,2,Terminated,TUBB,2
urethral neoplasm,PACLITAXEL,3,Completed,TUBB,2
carcinoma,PACLITAXEL,3,Unknown status,TUBB,2
Burkitts lymphoma,VINCRISTINE,1,Completed,TUBB,2
cancer,VINORELBINE,1,Completed,TUBB,2
cancer,PACLITAXEL,2,Recruiting,TUBB,2
Ewing sarcoma,VINCRISTINE,2,Terminated,TUBB,2
cancer,PACLITAXEL,2,Completed,TUBB,2
stomach neoplasm,PACLITAXEL,2,Recruiting,TUBB,1
stomach neoplasm,PACLITAXEL,2,Enrolling by invitation,TUBB,1
stomach neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,1
non-Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,1,Withdrawn,TUBB,1
stomach neoplasm,DOCETAXEL,3,Recruiting,TUBB,1
stomach neoplasm,PACLITAXEL,3,Recruiting,TUBB,1
non-Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,1,Recruiting,TUBB,1
uterine leiomyosarcoma,IXABEPILONE,2,Completed,TUBB,1
stomach neoplasm,DOCETAXEL,3,Completed,TUBB,1
uterine neoplasm,DOCETAXEL,2,Completed,TUBB,1
uterine neoplasm,PACLITAXEL,1,Completed,TUBB,1
stomach neoplasm,IXABEPILONE,2,Completed,TUBB,1
nodular sclerosis Hodgkin lymphoma,VINORELBINE,3,Unknown status,TUBB,1
neoplasm,PACLITAXEL,2,Recruiting,TUBB,1
stomach neoplasm,VINFLUNINE,2,Terminated,TUBB,1
testicular carcinoma,PACLITAXEL,2,Terminated,TUBB,1
thyroid carcinoma,PACLITAXEL,0,Recruiting,TUBB,1
neoplasm,DOCETAXEL,1,"Active, not recruiting",TUBB,1
nodular sclerosis Hodgkin lymphoma,BRENTUXIMAB VEDOTIN,2,"Active, not recruiting",TUBB,1
thyroid carcinoma,FOSBRETABULIN,3,Withdrawn,TUBB,1
thyroid carcinoma,CROLIBULIN,1,Completed,TUBB,1
neoplasm,CABAZITAXEL,4,n/a,TUBB,1
neoplasm,CABAZITAXEL,2,Recruiting,TUBB,1
urothelial carcinoma,VINFLUNINE,3,Completed,TUBB,1
neoplasm,CABAZITAXEL,1,Terminated,TUBB,1
uterine leiomyosarcoma,DOCETAXEL,2,Completed,TUBB,1
testicular neoplasm,DOCETAXEL,2,Completed,TUBB,1
nodular sclerosis Hodgkin lymphoma,VINBLASTINE,2,"Active, not recruiting",TUBB,1
stricture,PACLITAXEL,2,Terminated,TUBB,1
neoplasm,BRENTUXIMAB VEDOTIN,4,n/a,TUBB,1
testicular carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
testicular carcinoma,CABAZITAXEL,2,Recruiting,TUBB,1
systemic lupus erythematosus,BRENTUXIMAB VEDOTIN,2,Terminated,TUBB,1
stricture,VINBLASTINE,2,Completed,TUBB,1
uterine leiomyosarcoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
stricture,PACLITAXEL,2,Withdrawn,TUBB,1
uterine leiomyosarcoma,DOCETAXEL,3,Terminated,TUBB,1
nodular sclerosis Hodgkin lymphoma,VINCRISTINE,3,Unknown status,TUBB,1
nasopharyngeal neoplasm,PACLITAXEL,2,Unknown status,TUBB,1
uterine neoplasm,PACLITAXEL,1,Recruiting,TUBB,1
nasopharyngeal neoplasm,PACLITAXEL,2,Terminated,TUBB,1
uterine sarcoma,DOCETAXEL,2,Completed,TUBB,1
nasopharyngeal neoplasm,PACLITAXEL,2,Completed,TUBB,1
non-Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,3,"Active, not recruiting",TUBB,1
squamous cell lung carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,1,Terminated,TUBB,1
non-Hodgkins lymphoma,VINCRISTINE,3,Terminated,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,1,Completed,TUBB,1
non-Hodgkins lymphoma,VINCRISTINE,4,Unknown status,TUBB,1
verrucous carcinoma,IXABEPILONE,2,Completed,TUBB,1
squamous cell carcinoma,PACLITAXEL POLIGLUMEX,1,Unknown status,TUBB,1
non-Hodgkins lymphoma,VINORELBINE,2,Recruiting,TUBB,1
non-Hodgkins lymphoma,VINORELBINE,3,Completed,TUBB,1
nasopharyngeal neoplasm,DOCETAXEL,2,Recruiting,TUBB,1
squamous cell carcinoma,PACLITAXEL,3,Unknown status,TUBB,1
nasopharyngeal neoplasm,DOCETAXEL,2,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,0,Unknown status,TUBB,1
squamous cell carcinoma,PACLITAXEL,3,Terminated,TUBB,1
verrucous carcinoma,PACLITAXEL,1,Terminated,TUBB,1
vulvar carcinoma,DOCETAXEL,1,Completed,TUBB,1
nasal cavity squamous cell carcinoma,DOCETAXEL,2,Recruiting,TUBB,1
myocardial infarction,PACLITAXEL,3,Completed,TUBB,1
myocardial infarction,COLCHICINE,4,Completed,TUBB,1
squamous cell carcinoma,PACLITAXEL,3,Completed,TUBB,1
squamous cell carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
squamous cell carcinoma,PACLITAXEL,2,Withdrawn,TUBB,1
squamous cell carcinoma,PACLITAXEL,2,Terminated,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,3,Completed,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,3,Recruiting,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,3,Completed,TUBB,1
nasopharyngeal neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,1
non-Hodgkins lymphoma,PACLITAXEL,1,Terminated,TUBB,1
squamous cell lung carcinoma,VINORELBINE,3,Completed,TUBB,1
non-Hodgkins lymphoma,PACLITAXEL,2,Completed,TUBB,1
uterine neoplasm,PACLITAXEL,3,Unknown status,TUBB,1
non-Hodgkins lymphoma,PACLITAXEL,3,Completed,TUBB,1
thyroid carcinoma,PACLITAXEL,1,Completed,TUBB,1
non-Hodgkins lymphoma,VINBLASTINE,4,Unknown status,TUBB,1
uterine sarcoma,IXABEPILONE,2,Completed,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,4,Not yet recruiting,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
squamous cell lung carcinoma,DOCETAXEL,4,Unknown status,TUBB,1
non-Hodgkins lymphoma,VINCRISTINE,1,Recruiting,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,2,Completed,TUBB,1
non-Hodgkins lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
squamous cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
squamous cell lung carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
non-Hodgkins lymphoma,VINCRISTINE,2,Unknown status,TUBB,1
uterine sarcoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
squamous cell lung carcinoma,PACLITAXEL,1,Terminated,TUBB,1
squamous cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
vascular disease,COLCHICINE,2,Completed,TUBB,1
neuroendocrine neoplasm,PACLITAXEL,2,Recruiting,TUBB,1
thyroid carcinoma,PACLITAXEL,3,Withdrawn,TUBB,1
neuroblastoma,VINORELBINE,2,Completed,TUBB,1
neoplasm,VINFLUNINE,4,n/a,TUBB,1
upper aerodigestive tract neoplasm,DOCETAXEL,3,Completed,TUBB,1
upper aerodigestive tract neoplasm,DOCETAXEL,2,Terminated,TUBB,1
upper aerodigestive tract neoplasm,DOCETAXEL,2,Not yet recruiting,TUBB,1
upper aerodigestive tract neoplasm,DOCETAXEL,1,Unknown status,TUBB,1
urogenital neoplasm,PACLITAXEL,1,Recruiting,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,4,Recruiting,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,4,Completed,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,3,Unknown status,TUBB,1
urogenital neoplasm,PACLITAXEL,3,"Active, not recruiting",TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,3,Not yet recruiting,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,3,Completed,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,3,"Active, not recruiting",TUBB,1
urogenital neoplasm,VINFLUNINE,3,"Active, not recruiting",TUBB,1
neoplasm,MIRVETUXIMAB SORAVTANSINE,1,"Active, not recruiting",TUBB,1
neoplasm,VINCRISTINE,2,Recruiting,TUBB,1
neoplasm,IXABEPILONE,4,n/a,TUBB,1
neoplasm,VINCRISTINE,3,"Active, not recruiting",TUBB,1
neoplasm,VINCRISTINE,4,n/a,TUBB,1
neoplasm,IXABEPILONE,1,Withdrawn,TUBB,1
urogenital neoplasm,VINFLUNINE,3,Recruiting,TUBB,1
neoplasm,IXABEPILONE,1,"Active, not recruiting",TUBB,1
urothelial carcinoma,CABAZITAXEL,2,Recruiting,TUBB,1
neoplasm,VINFLUNINE,1,Completed,TUBB,1
upper aerodigestive tract neoplasm,DOCETAXEL,4,Completed,TUBB,1
neoplasm,VINBLASTINE,4,n/a,TUBB,1
upper aerodigestive tract neoplasm,PACLITAXEL,1,Completed,TUBB,1
urethral neoplasm,VINBLASTINE,3,Completed,TUBB,1
urethral neoplasm,IXABEPILONE,2,Completed,TUBB,1
neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,1
neoplasm,PACLITAXEL,2,Withdrawn,TUBB,1
ureteral neoplasm,IXABEPILONE,2,Completed,TUBB,1
neoplasm,PACLITAXEL,3,Unknown status,TUBB,1
neoplasm,PACLITAXEL,4,Unknown status,TUBB,1
urethral neoplasm,PACLITAXEL,2,Terminated,TUBB,1
upper aerodigestive tract neoplasm,VINORELBINE,2,Unknown status,TUBB,1
urethral neoplasm,VINBLASTINE,2,Completed,TUBB,1
neoplasm,PACLITAXEL,4,n/a,TUBB,1
urogenital neoplasm,DOCETAXEL,3,"Active, not recruiting",TUBB,1
neoplasm,VINBLASTINE,2,Unknown status,TUBB,1
neoplasm,PACLITAXEL POLIGLUMEX,4,n/a,TUBB,1
upper aerodigestive tract neoplasm,PACLITAXEL,3,Unknown status,TUBB,1
neoplasm,SAGOPILONE,1,Completed,TUBB,1
urogenital neoplasm,DOCETAXEL,3,Recruiting,TUBB,1
upper aerodigestive tract neoplasm,PACLITAXEL,2,Unknown status,TUBB,1
neoplasm,TRASTUZUMAB EMTANSINE,2,Completed,TUBB,1
upper aerodigestive tract neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,1
neoplasm,VERUBULIN,1,Completed,TUBB,1
neoplasm,VINBLASTINE,2,Completed,TUBB,1
neoplasm,VINBLASTINE,2,Recruiting,TUBB,1
squamous cell carcinoma,PACLITAXEL,1,Completed,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
thyroid carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
neoplasm,INDIBULIN,1,Completed,TUBB,1
triple-negative breast cancer,PACLITAXEL,1,Recruiting,TUBB,1
triple-negative breast cancer,ERIBULIN,2,"Active, not recruiting",TUBB,1
urothelial carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
triple-negative breast cancer,DOCETAXEL,2,"Active, not recruiting",TUBB,1
urothelial carcinoma,ERIBULIN,1,Recruiting,TUBB,1
transitional cell carcinoma of kidney,VINBLASTINE,3,Completed,TUBB,1
transitional cell carcinoma of kidney,VINBLASTINE,2,Completed,TUBB,1
neoplasm,DOCETAXEL,1,Withdrawn,TUBB,1
neuroblastoma,VINCRISTINE,1,Recruiting,TUBB,1
transitional cell carcinoma of kidney,PACLITAXEL,2,Terminated,TUBB,1
transitional cell carcinoma of kidney,IXABEPILONE,2,Completed,TUBB,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Unknown status,TUBB,1
transitional cell carcinoma of kidney,DOCETAXEL,2,Completed,TUBB,1
tongue neoplasm,IXABEPILONE,2,Completed,TUBB,1
urethral neoplasm,DOCETAXEL,2,Completed,TUBB,1
thyroid carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
thyroid carcinoma,PACLITAXEL,2,Terminated,TUBB,1
urothelial carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
thyroid carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
urothelial carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
urothelial carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
urothelial carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
neuroblastoma,VINCRISTINE,3,Recruiting,TUBB,1
neoplasm,DOCETAXEL,2,Recruiting,TUBB,1
neoplasm of mature B-cells,VINCRISTINE,2,Unknown status,TUBB,1
neoplasm,DOCETAXEL,2,Unknown status,TUBB,1
undifferentiated carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
neoplasm,FOSBRETABULIN,2,Completed,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,1,Recruiting,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,1,Completed,TUBB,1
unspecified peripheral T-cell lymphoma,VINCRISTINE,1,"Active, not recruiting",TUBB,1
urothelial carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
neoplasm,ERIBULIN,4,n/a,TUBB,1
neoplasm,VINORELBINE,1,Terminated,TUBB,1
neoplasm,ERIBULIN,2,Not yet recruiting,TUBB,1
urothelial carcinoma,DOCETAXEL,2,Recruiting,TUBB,1
unspecified peripheral T-cell lymphoma,BRENTUXIMAB VEDOTIN,2,Recruiting,TUBB,1
neoplasm,VINORELBINE,2,Recruiting,TUBB,1
neoplasm of mature B-cells,VINCRISTINE,2,Not yet recruiting,TUBB,1
neoplasm,ERIBULIN,1,"Active, not recruiting",TUBB,1
neoplasm,VINORELBINE,4,n/a,TUBB,1
neoplasm of mature B-cells,VINCRISTINE,1,Completed,TUBB,1
triple-negative breast cancer,PACLITAXEL,3,"Active, not recruiting",TUBB,1
neoplasm,DOCETAXEL,4,n/a,TUBB,1
neoplasm of mature B-cells,VINCRISTINE,1,Terminated,TUBB,1
neoplasm,DOCETAXEL,4,Unknown status,TUBB,1
neoplasm of mature B-cells,VINCRISTINE,2,"Active, not recruiting",TUBB,1
triple-negative breast cancer,PACLITAXEL,2,Recruiting,TUBB,1
neoplasm,DOCETAXEL,2,Withdrawn,TUBB,1
squamous cell carcinoma,PACLITAXEL,1,Recruiting,TUBB,1
small cell carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
squamous cell carcinoma,PACLITAXEL,0,Not yet recruiting,TUBB,1
prostate adenocarcinoma,DOCETAXEL,4,Completed,TUBB,1
ovarian clear cell adenocarcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
prostate adenocarcinoma,DOCETAXEL,3,Unknown status,TUBB,1
ovarian cystadenocarcinoma,DOCETAXEL,1,Completed,TUBB,1
ovarian cystadenocarcinoma,DOCETAXEL,2,Completed,TUBB,1
prostate adenocarcinoma,DOCETAXEL,3,Not yet recruiting,TUBB,1
ovarian cystadenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
prostate adenocarcinoma,DOCETAXEL,2,Withdrawn,TUBB,1
ovarian mucinous adenocarcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
ovarian mucinous adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
ovarian mucinous adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
ovarian mucinous adenocarcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
ovarian mucinous cystadenocarcinoma,DOCETAXEL,1,Completed,TUBB,1
ovarian mucinous cystadenocarcinoma,PACLITAXEL,2,Completed,TUBB,1
ovarian mucinous cystadenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
prostate adenocarcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
prostate adenocarcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
ovarian neoplasm,PACLITAXEL,2,Recruiting,TUBB,1
ovarian neoplasm,PACLITAXEL,2,Terminated,TUBB,1
ovarian neoplasm,PACLITAXEL,3,Recruiting,TUBB,1
ovarian neoplasm,PACLITAXEL,3,Terminated,TUBB,1
prostate adenocarcinoma,DOCETAXEL,1,Recruiting,TUBB,1
prostate adenocarcinoma,CABAZITAXEL,3,Recruiting,TUBB,1
prostate adenocarcinoma,CABAZITAXEL,3,Completed,TUBB,1
prostate adenocarcinoma,CABAZITAXEL,2,Completed,TUBB,1
ovarian serous adenocarcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
prostate adenocarcinoma,CABAZITAXEL,1,Withdrawn,TUBB,1
prostate adenocarcinoma,CABAZITAXEL,1,Terminated,TUBB,1
ovarian clear cell adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
prostate adenocarcinoma,ERIBULIN,2,Completed,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,2,Enrolling by invitation,TUBB,1
prostate adenocarcinoma,IXABEPILONE,1,Completed,TUBB,1
ovarian carcinoma,IXABEPILONE,2,Completed,TUBB,1
ovarian carcinoma,IXABEPILONE,2,Recruiting,TUBB,1
ovarian carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Recruiting,TUBB,1
prostate carcinoma,DOCETAXEL,2,Suspended,TUBB,1
prostate carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
prostate carcinoma,DOCETAXEL,1,Not yet recruiting,TUBB,1
prostate carcinoma,DOCETAXEL,0,Recruiting,TUBB,1
prostate carcinoma,COLCHICINE,2,Withdrawn,TUBB,1
prostate carcinoma,CABAZITAXEL,4,"Active, not recruiting",TUBB,1
prostate carcinoma,CABAZITAXEL,3,Terminated,TUBB,1
ovarian carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
prostate carcinoma,CABAZITAXEL,3,"Active, not recruiting",TUBB,1
prostate carcinoma,CABAZITAXEL,2,Withdrawn,TUBB,1
prostate carcinoma,CABAZITAXEL,2,Not yet recruiting,TUBB,1
prostate carcinoma,CABAZITAXEL,2,Enrolling by invitation,TUBB,1
ovarian carcinoma,PACLITAXEL,2,Withdrawn,TUBB,1
prostate carcinoma,CABAZITAXEL,1,"Active, not recruiting",TUBB,1
prostate adenocarcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,1
prostate adenocarcinoma,PACLITAXEL,2,Terminated,TUBB,1
ovarian carcinoma,PACLITAXEL,4,Unknown status,TUBB,1
prostate adenocarcinoma,IXABEPILONE,2,Terminated,TUBB,1
ovarian carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB,1
ovarian carcinoma,VINORELBINE,2,Completed,TUBB,1
ovarian clear cell adenocarcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
ovarian clear cell adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,1
ovarian clear cell adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
ovarian clear cell adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
ovarian serous adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
proliferative vitreoretinopathy,COLCHICINE,3,Unknown status,TUBB,1
primitive neuroectodermal tumor,VINCRISTINE,2,Completed,TUBB,1
primary biliary cirrhosis,COLCHICINE,3,Completed,TUBB,1
pancreatic carcinoma,PACLITAXEL,0,Recruiting,TUBB,1
peritoneal neoplasm,DOCETAXEL,3,Completed,TUBB,1
pancreatic carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
peritoneal neoplasm,DOCETAXEL,2,Unknown status,TUBB,1
peritoneal neoplasm,DOCETAXEL,1,Terminated,TUBB,1
pancreatic carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
peripheral vascular disease,PACLITAXEL,2,Terminated,TUBB,1
myelodysplastic syndrome,VINCRISTINE,1,Recruiting,TUBB,1
pancreatic carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB,1
peripheral neuropathy,PACLITAXEL,1,Recruiting,TUBB,1
peripheral arterial disease,PACLITAXEL,3,Recruiting,TUBB,1
peripheral arterial disease,PACLITAXEL,3,"Active, not recruiting",TUBB,1
peripheral arterial disease,PACLITAXEL,1,Completed,TUBB,1
pancreatic carcinoma,PACLITAXEL,3,Completed,TUBB,1
pericarditis,COLCHICINE,4,Completed,TUBB,1
pancreatic carcinoma,PACLITAXEL,3,Terminated,TUBB,1
pancreatic carcinoma,PACLITAXEL,4,Recruiting,TUBB,1
pancreatic ductal adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,1
pancreatic ductal adenocarcinoma,PACLITAXEL,1,Terminated,TUBB,1
pancreatic ductal adenocarcinoma,PACLITAXEL,2,Completed,TUBB,1
penile neoplasm,VINFLUNINE,2,"Active, not recruiting",TUBB,1
penile neoplasm,PACLITAXEL,2,Completed,TUBB,1
pancreatic ductal adenocarcinoma,PACLITAXEL,2,Unknown status,TUBB,1
penile neoplasm,DOCETAXEL,2,Terminated,TUBB,1
pancreatic ductal adenocarcinoma,PACLITAXEL,3,Terminated,TUBB,1
pancreatic neoplasm,DOCETAXEL,2,Terminated,TUBB,1
pancreatic neoplasm,DOCETAXEL,2,Unknown status,TUBB,1
peritoneal neoplasm,IXABEPILONE,2,Completed,TUBB,1
peritoneal neoplasm,IXABEPILONE,2,Recruiting,TUBB,1
peritoneal neoplasm,MIRVETUXIMAB SORAVTANSINE,1,Recruiting,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB,1
ovarian serous adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
precursor T-cell lymphoblastic leukemia-lymphoma,VINCRISTINE,1,Terminated,TUBB,1
ovarian serous adenocarcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
ovarian serous cystadenocarcinoma,DOCETAXEL,1,Completed,TUBB,1
pharynx cancer,DOCETAXEL,3,Completed,TUBB,1
ovarian serous cystadenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
ovarian serous cystadenocarcinoma,PACLITAXEL,2,Completed,TUBB,1
ovarian serous cystadenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
peritoneal neoplasm,VINORELBINE,2,Completed,TUBB,1
pancreatic adenocarcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
peritoneal neoplasm,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
pancreatic adenocarcinoma,ERIBULIN,2,Completed,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,0,Unknown status,TUBB,1
peritoneal neoplasm,PACLITAXEL,1,Suspended,TUBB,1
peritoneal neoplasm,PACLITAXEL POLIGLUMEX,1,Completed,TUBB,1
peritoneal neoplasm,PACLITAXEL,3,Unknown status,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,1,Unknown status,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
peritoneal neoplasm,PACLITAXEL,3,Terminated,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
peritoneal neoplasm,PACLITAXEL,1,Withdrawn,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
pancreatic adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB,1
peritoneal neoplasm,PACLITAXEL,1,Unknown status,TUBB,1
pancreatic carcinoma,DOCETAXEL,1,Completed,TUBB,1
ovarian carcinoma,FOSBRETABULIN,2,Terminated,TUBB,1
ovarian carcinoma,FOSBRETABULIN,1,Terminated,TUBB,1
prostate carcinoma,ERIBULIN,2,Completed,TUBB,1
sarcoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
small cell lung carcinoma,DOCETAXEL,2,Withdrawn,TUBB,1
small cell lung carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
small cell lung carcinoma,CABAZITAXEL,2,Completed,TUBB,1
penile neoplasm,CABAZITAXEL,2,Completed,TUBB,1
sex cord-gonadal stromal tumor,PACLITAXEL,2,"Active, not recruiting",TUBB,1
schizophrenia,DAVUNETIDE,2,Completed,TUBB,1
sarcoma,VINORELBINE,3,Unknown status,TUBB,1
sarcoma,VINCRISTINE,3,Withdrawn,TUBB,1
sarcoma,VINCRISTINE,3,"Active, not recruiting",TUBB,1
sarcoma,VINCRISTINE,2,Terminated,TUBB,1
sarcoma,VINCRISTINE,2,Recruiting,TUBB,1
sarcoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
sarcoma,VINCRISTINE,1,Completed,TUBB,1
sarcoma,VINBLASTINE,2,Completed,TUBB,1
sarcoma,PACLITAXEL,3,Completed,TUBB,1
sarcoma,PACLITAXEL,1,Suspended,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,4,Completed,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,4,Unknown status,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB,1
sarcoma,PACLITAXEL,1,Completed,TUBB,1
sarcoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
non-small cell lung carcinoma,PACLITAXEL POLIGLUMEX,3,Terminated,TUBB,1
sarcoma,IXABEPILONE,2,Terminated,TUBB,1
sarcoma,ERIBULIN,2,Recruiting,TUBB,1
sarcoma,DOCETAXEL,3,Recruiting,TUBB,1
non-small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB,1
small cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,1
small cell lung carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
small cell lung carcinoma,PLINABULIN,1,Recruiting,TUBB,1
soft tissue sarcoma,DOCETAXEL,2,Unknown status,TUBB,1
squamous cell carcinoma,DOCETAXEL,4,Completed,TUBB,1
squamous cell carcinoma,DOCETAXEL,3,Completed,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,2,Suspended,TUBB,1
squamous cell carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
squamous cell carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
soft tissue sarcoma,PACLITAXEL,2,Terminated,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,3,Suspended,TUBB,1
soft tissue sarcoma,PACLITAXEL,1,Recruiting,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,4,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,DOCETAXEL,4,Terminated,TUBB,1
soft tissue sarcoma,ERIBULIN,3,Completed,TUBB,1
non-small cell lung carcinoma,ERIBULIN,1,Unknown status,TUBB,1
non-small cell lung carcinoma,ERIBULIN,3,Completed,TUBB,1
small cell lung carcinoma,SAGOPILONE,1,Completed,TUBB,1
soft tissue sarcoma,DOCETAXEL,2,Recruiting,TUBB,1
soft tissue sarcoma,DOCETAXEL,1,Recruiting,TUBB,1
non-small cell lung carcinoma,IXABEPILONE,2,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,0,Recruiting,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,0,Terminated,TUBB,1
non-small cell lung carcinoma,PACLITAXEL,0,Unknown status,TUBB,1
soft tissue sarcoma,DOCETAXEL,1,Completed,TUBB,1
small intestine carcinoma,PACLITAXEL,1,Completed,TUBB,1
small cell lung carcinoma,VINORELBINE,1,Completed,TUBB,1
small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB,1
small cell lung carcinoma,VINCRISTINE,3,"Active, not recruiting",TUBB,1
small cell lung carcinoma,SAGOPILONE,2,Terminated,TUBB,1
non-small cell lung carcinoma,PLINABULIN,1,Terminated,TUBB,1
non-small cell lung carcinoma,PLINABULIN,3,Recruiting,TUBB,1
prostate carcinoma,IXABEPILONE,1,Completed,TUBB,1
sarcoma,DOCETAXEL,1,Recruiting,TUBB,1
prostate carcinoma,VINORELBINE,2,Unknown status,TUBB,1
obesity,COLCHICINE,1,Completed,TUBB,1
prostate carcinoma,VINORELBINE,1,Completed,TUBB,1
prostate carcinoma,VINFLUNINE,2,Completed,TUBB,1
prostate carcinoma,VINBLASTINE,3,Terminated,TUBB,1
prostate carcinoma,VINBLASTINE,2,Completed,TUBB,1
prostate carcinoma,SAGOPILONE,2,Completed,TUBB,1
oral squamous cell carcinoma,DOCETAXEL,2,Completed,TUBB,1
prostate carcinoma,PACLITAXEL POLIGLUMEX,2,Terminated,TUBB,1
oropharynx cancer,DOCETAXEL,3,Recruiting,TUBB,1
osteoarthritis,COLCHICINE,2,Completed,TUBB,1
osteosarcoma,DOCETAXEL,1,Recruiting,TUBB,1
osteosarcoma,DOCETAXEL,2,Recruiting,TUBB,1
osteosarcoma,DOCETAXEL,2,Unknown status,TUBB,1
osteosarcoma,ERIBULIN,2,Completed,TUBB,1
osteosarcoma,VINCRISTINE,1,Completed,TUBB,1
ovarian carcinoma,CABAZITAXEL,2,"Active, not recruiting",TUBB,1
prostate carcinoma,PACLITAXEL,2,Terminated,TUBB,1
ovarian carcinoma,CABAZITAXEL,2,Terminated,TUBB,1
prostate carcinoma,PACLITAXEL,1,Unknown status,TUBB,1
ovarian carcinoma,DOCETAXEL,1,Terminated,TUBB,1
ovarian carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
ovarian carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
prostate carcinoma,PACLITAXEL,1,Terminated,TUBB,1
prostate carcinoma,IXABEPILONE,1,Terminated,TUBB,1
ovarian carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
ovarian carcinoma,DOCETAXEL,3,Completed,TUBB,1
non-small cell lung carcinoma,VINORELBINE,3,Withdrawn,TUBB,1
prostate carcinoma,VINORELBINE,2,Withdrawn,TUBB,1
psoriasis,PACLITAXEL,2,Completed,TUBB,1
rhabdomyosarcoma,VINCRISTINE,3,Unknown status,TUBB,1
salivary gland squamous cell carcinoma,PACLITAXEL,1,Terminated,TUBB,1
non-small cell lung carcinoma,SAGOPILONE,2,Completed,TUBB,1
non-small cell lung carcinoma,TRASTUZUMAB EMTANSINE,2,Completed,TUBB,1
salivary gland squamous cell carcinoma,IXABEPILONE,2,Completed,TUBB,1
salivary gland neoplasm,PACLITAXEL,2,Recruiting,TUBB,1
non-small cell lung carcinoma,VINBLASTINE,3,Not yet recruiting,TUBB,1
non-small cell lung carcinoma,VINFLUNINE,2,Completed,TUBB,1
salivary gland neoplasm,ERIBULIN,2,Completed,TUBB,1
non-small cell lung carcinoma,VINORELBINE,1,Terminated,TUBB,1
rheumatoid arthritis,PACLITAXEL,2,Completed,TUBB,1
non-small cell lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,1
rhegmatogenous retinal detachment,COLCHICINE,3,Unknown status,TUBB,1
rhabdomyosarcoma,VINCRISTINE,3,Terminated,TUBB,1
rectum cancer,PACLITAXEL,1,"Active, not recruiting",TUBB,1
rhabdomyosarcoma,VINCRISTINE,2,Recruiting,TUBB,1
rhabdomyosarcoma,VINCRISTINE,2,Completed,TUBB,1
rhabdomyosarcoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
renal cell carcinoma,VINBLASTINE,2,Completed,TUBB,1
renal cell carcinoma,PACLITAXEL,1,Completed,TUBB,1
renal cell carcinoma,IXABEPILONE,2,Completed,TUBB,1
renal carcinoma,VINORELBINE,2,Completed,TUBB,1
renal carcinoma,VINCRISTINE,2,Unknown status,TUBB,1
renal carcinoma,VINBLASTINE,2,Unknown status,TUBB,1
renal carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
renal carcinoma,PACLITAXEL,2,Completed,TUBB,1
renal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
myocardial infarction,COLCHICINE,2,Recruiting,TUBB,1
B-cell acute lymphoblastic leukemia,VINCRISTINE,1,Recruiting,TUBB,1
myelodysplastic syndrome,DOCETAXEL,1,Completed,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
breast carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
breast carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
breast carcinoma,DOCETAXEL,0,Completed,TUBB,1
breast carcinoma,CABAZITAXEL,2,Terminated,TUBB,1
breast carcinoma,CABAZITAXEL,2,Recruiting,TUBB,1
breast carcinoma,CABAZITAXEL,2,Completed,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,Suspended,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB,1
breast adenocarcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
breast adenocarcinoma,ERIBULIN,3,Suspended,TUBB,1
anal neoplasm,DOCETAXEL,2,"Active, not recruiting",TUBB,1
breast adenocarcinoma,ERIBULIN,1,Recruiting,TUBB,1
brain neoplasm,VINCRISTINE,1,Recruiting,TUBB,1
brain neoplasm,VERUBULIN,1,Completed,TUBB,1
brain neoplasm,PACLITAXEL POLIGLUMEX,2,Completed,TUBB,1
brain neoplasm,ERIBULIN,0,"Active, not recruiting",TUBB,1
brain neoplasm,CABAZITAXEL,1,Withdrawn,TUBB,1
bladder tumor,PACLITAXEL,2,Terminated,TUBB,1
bladder transitional cell carcinoma,PACLITAXEL,2,Withdrawn,TUBB,1
bladder transitional cell carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
breast carcinoma,DOCETAXEL,3,Withdrawn,TUBB,1
breast carcinoma,DOCETAXEL,4,Withdrawn,TUBB,1
breast carcinoma,ERIBULIN,1,Terminated,TUBB,1
breast carcinoma,ERIBULIN,1,Unknown status,TUBB,1
breast carcinoma,PACLITAXEL,3,Withdrawn,TUBB,1
breast carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
breast carcinoma,PACLITAXEL,2,Enrolling by invitation,TUBB,1
breast carcinoma,PACLITAXEL,0,"Active, not recruiting",TUBB,1
breast carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Withdrawn,TUBB,1
breast carcinoma,IXABEPILONE,4,n/a,TUBB,1
breast carcinoma,IXABEPILONE,2,Withdrawn,TUBB,1
breast carcinoma,IXABEPILONE,2,Recruiting,TUBB,1
breast carcinoma,IXABEPILONE,1,Withdrawn,TUBB,1
breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB,1
breast carcinoma,INDIBULIN,1,Unknown status,TUBB,1
breast carcinoma,ERIBULIN,4,n/a,TUBB,1
breast carcinoma,ERIBULIN,4,Completed,TUBB,1
breast carcinoma,ERIBULIN,4,"Active, not recruiting",TUBB,1
breast carcinoma,ERIBULIN,3,Not yet recruiting,TUBB,1
breast carcinoma,ERIBULIN,3,"Active, not recruiting",TUBB,1
breast carcinoma,ERIBULIN,2,Withdrawn,TUBB,1
breast carcinoma,ERIBULIN,2,Unknown status,TUBB,1
breast carcinoma,ERIBULIN,1,Withdrawn,TUBB,1
bladder transitional cell carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
bladder transitional cell carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
bladder transitional cell carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
atrial fibrillation,COLCHICINE,3,Completed,TUBB,1
aphthous ulcer,COLCHICINE,2,Unknown status,TUBB,1
angiosarcoma,PACLITAXEL,2,Unknown status,TUBB,1
angiosarcoma,PACLITAXEL,2,Terminated,TUBB,1
angiosarcoma,ERIBULIN,2,Recruiting,TUBB,1
angioimmunoblastic T-cell lymphoma,VINCRISTINE,2,Recruiting,TUBB,1
angioimmunoblastic T-cell lymphoma,VINCRISTINE,2,Completed,TUBB,1
angioimmunoblastic T-cell lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
anaplastic large cell lymphoma,VINCRISTINE,2,Terminated,TUBB,1
anaplastic large cell lymphoma,VINCRISTINE,2,Completed,TUBB,1
anaplastic large cell lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
anaplastic large cell lymphoma,IXABEPILONE,2,Completed,TUBB,1
anaplastic large cell lymphoma,BRENTUXIMAB VEDOTIN,4,n/a,TUBB,1
anaplastic large cell lymphoma,BRENTUXIMAB VEDOTIN,3,Completed,TUBB,1
anaplastic large cell lymphoma,BRENTUXIMAB VEDOTIN,2,Suspended,TUBB,1
anaplastic large cell lymphoma,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,1
anaplastic large cell lymphoma,BRENTUXIMAB VEDOTIN,1,Recruiting,TUBB,1
anaplastic large cell lymphoma,BRENTUXIMAB VEDOTIN,1,"Active, not recruiting",TUBB,1
anaplastic astrocytoma,VINCRISTINE,2,Completed,TUBB,1
anaplastic astrocytoma,IXABEPILONE,1,Completed,TUBB,1
atrial fibrillation,COLCHICINE,2,Unknown status,TUBB,1
atrial fibrillation,COLCHICINE,3,Recruiting,TUBB,1
bladder transitional cell carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
atrial fibrillation,COLCHICINE,3,Withdrawn,TUBB,1
bladder transitional cell carcinoma,DOCETAXEL,2,Completed,TUBB,1
bladder transitional cell carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
bladder transitional cell carcinoma,CABAZITAXEL,2,Completed,TUBB,1
bladder carcinoma,VINORELBINE,1,Completed,TUBB,1
bladder carcinoma,VINFLUNINE,1,Withdrawn,TUBB,1
bladder carcinoma,VINFLUNINE,1,Completed,TUBB,1
bladder carcinoma,VINBLASTINE,3,Terminated,TUBB,1
bladder carcinoma,VINBLASTINE,3,Recruiting,TUBB,1
bladder carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
bladder carcinoma,PACLITAXEL,1,Unknown status,TUBB,1
bladder carcinoma,IXABEPILONE,2,Completed,TUBB,1
bladder carcinoma,DOCETAXEL,3,Completed,TUBB,1
bladder carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
bladder carcinoma,CABAZITAXEL,1,"Active, not recruiting",TUBB,1
biliary tract neoplasm,PACLITAXEL,2,"Active, not recruiting",TUBB,1
biliary tract neoplasm,DOCETAXEL,2,Unknown status,TUBB,1
benign prostatic hyperplasia,PACLITAXEL,2,Recruiting,TUBB,1
autoimmune thrombocytopenic purpura,VINCRISTINE,4,Completed,TUBB,1
autoimmune thrombocytopenic purpura,VINCRISTINE,2,Completed,TUBB,1
breast carcinoma,PACLITAXEL,4,Withdrawn,TUBB,1
breast carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB,1
breast carcinoma,PACLITAXEL POLIGLUMEX,2,Withdrawn,TUBB,1
carcinoma,PACLITAXEL,1,Completed,TUBB,1
carcinoma,DOCETAXEL,2,Withdrawn,TUBB,1
carcinoma,DOCETAXEL,2,Terminated,TUBB,1
carcinoma,DOCETAXEL,2,Recruiting,TUBB,1
carcinoma,DOCETAXEL,1,Completed,TUBB,1
cancer,VINORELBINE,2,"Active, not recruiting",TUBB,1
cancer,VINORELBINE,1,Unknown status,TUBB,1
cancer,VINORELBINE,1,Recruiting,TUBB,1
cancer,VINORELBINE,1,Not yet recruiting,TUBB,1
cancer,VINFLUNINE,1,Withdrawn,TUBB,1
cancer,VINCRISTINE,4,Unknown status,TUBB,1
cancer,PLINABULIN,1,Completed,TUBB,1
cancer,PACLITAXEL,4,Completed,TUBB,1
cancer,PACLITAXEL,2,"Active, not recruiting",TUBB,1
cancer,PACLITAXEL,1,Suspended,TUBB,1
cancer,INDIBULIN,1,Completed,TUBB,1
cancer,FOSBRETABULIN,2,Completed,TUBB,1
cancer,ERIBULIN,2,Recruiting,TUBB,1
cancer,ERIBULIN,1,Recruiting,TUBB,1
cancer,DOCETAXEL,3,Unknown status,TUBB,1
carcinoma,DOCETAXEL,3,Unknown status,TUBB,1
carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
cancer,DOCETAXEL,2,"Active, not recruiting",TUBB,1
carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
cervical adenocarcinoma,PACLITAXEL,3,Recruiting,TUBB,1
cervical adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
cervical adenocarcinoma,PACLITAXEL,2,Unknown status,TUBB,1
cervical adenocarcinoma,DOCETAXEL,2,Completed,TUBB,1
central nervous system cancer,VINORELBINE,2,"Active, not recruiting",TUBB,1
central nervous system cancer,VINCRISTINE,3,"Active, not recruiting",TUBB,1
central nervous system cancer,VINBLASTINE,2,Completed,TUBB,1
central nervous system cancer,VINBLASTINE,2,"Active, not recruiting",TUBB,1
central nervous system cancer,VINBLASTINE,1,Recruiting,TUBB,1
central nervous system cancer,VINBLASTINE,1,Completed,TUBB,1
central nervous system cancer,SAGOPILONE,2,Completed,TUBB,1
central nervous system cancer,PACLITAXEL,1,Terminated,TUBB,1
cardiac arrhythmia,COLCHICINE,3,Completed,TUBB,1
carcinoma,VINORELBINE,3,Unknown status,TUBB,1
carcinoma,VINORELBINE,2,Terminated,TUBB,1
carcinoma,VINORELBINE,2,Completed,TUBB,1
carcinoma,VINCRISTINE,3,Unknown status,TUBB,1
carcinoma,VINCRISTINE,2,Completed,TUBB,1
carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
cancer,DOCETAXEL,3,Completed,TUBB,1
cancer,DOCETAXEL,1,Unknown status,TUBB,1
breast carcinoma,SAGOPILONE,2,Completed,TUBB,1
breast neoplasm,ERIBULIN,3,Completed,TUBB,1
breast neoplasm,ERIBULIN,2,Recruiting,TUBB,1
breast neoplasm,ERIBULIN,2,Completed,TUBB,1
breast neoplasm,DOCETAXEL,4,Recruiting,TUBB,1
breast neoplasm,DOCETAXEL,3,"Active, not recruiting",TUBB,1
breast neoplasm,DOCETAXEL,2,"Active, not recruiting",TUBB,1
breast ductal adenocarcinoma,PACLITAXEL,2,Unknown status,TUBB,1
breast carcinoma,VINORELBINE,4,Completed,TUBB,1
breast carcinoma,VINORELBINE,3,Not yet recruiting,TUBB,1
breast carcinoma,VINORELBINE,3,"Active, not recruiting",TUBB,1
breast carcinoma,VINORELBINE,0,Completed,TUBB,1
breast carcinoma,VINFLUNINE,2,Withdrawn,TUBB,1
breast carcinoma,VINFLUNINE,2,Completed,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,n/a,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,4,"Active, not recruiting",TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Terminated,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,3,Recruiting,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,2,Withdrawn,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Withdrawn,TUBB,1
breast carcinoma,TRASTUZUMAB EMTANSINE,1,Terminated,TUBB,1
breast neoplasm,ERIBULIN,2,Terminated,TUBB,1
breast neoplasm,ERIBULIN,4,Completed,TUBB,1
cancer,DOCETAXEL,1,Terminated,TUBB,1
breast neoplasm,ERIBULIN,4,Recruiting,TUBB,1
cancer,DOCETAXEL,1,Suspended,TUBB,1
cancer,DOCETAXEL,1,Recruiting,TUBB,1
cancer,DOCETAXEL,1,"Active, not recruiting",TUBB,1
cancer,CROLIBULIN,1,Completed,TUBB,1
cancer,CABAZITAXEL,2,Terminated,TUBB,1
cancer,CABAZITAXEL,1,Completed,TUBB,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,Completed,TUBB,1
bronchoalveolar adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
breast neoplasm,VINORELBINE,2,Withdrawn,TUBB,1
breast neoplasm,VINFLUNINE,3,Completed,TUBB,1
breast neoplasm,VINFLUNINE,2,Completed,TUBB,1
breast neoplasm,TRASTUZUMAB EMTANSINE,3,Completed,TUBB,1
breast neoplasm,TRASTUZUMAB EMTANSINE,1,Completed,TUBB,1
breast neoplasm,PACLITAXEL,3,Terminated,TUBB,1
breast neoplasm,PACLITAXEL,1,Unknown status,TUBB,1
breast neoplasm,PACLITAXEL,1,Terminated,TUBB,1
breast neoplasm,MIRVETUXIMAB SORAVTANSINE,2,Recruiting,TUBB,1
breast neoplasm,IXABEPILONE,2,Terminated,TUBB,1
breast neoplasm,IXABEPILONE,2,Recruiting,TUBB,1
anal neoplasm,PACLITAXEL,1,Terminated,TUBB,1
alveolar rhabdomyosarcoma,VINORELBINE,3,Recruiting,TUBB,1
mycosis fungoides,BRENTUXIMAB VEDOTIN,3,Completed,TUBB,1
Hereditary breast and ovarian cancer syndrome,DOCETAXEL,2,Completed,TUBB,1
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,4,n/a,TUBB,1
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,4,Recruiting,TUBB,1
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,4,"Active, not recruiting",TUBB,1
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,2,Unknown status,TUBB,1
Hodgkins lymphoma,BRENTUXIMAB VEDOTIN,1,Withdrawn,TUBB,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,2,Recruiting,TUBB,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Recruiting,TUBB,1
Hereditary breast and ovarian cancer syndrome,PACLITAXEL,1,Completed,TUBB,1
Hereditary breast and ovarian cancer syndrome,ERIBULIN,2,Withdrawn,TUBB,1
Hepatoblastoma,VINCRISTINE,3,"Active, not recruiting",TUBB,1
alveolar rhabdomyosarcoma,VINORELBINE,2,Completed,TUBB,1
HIV-1 infection,VINCRISTINE,3,"Active, not recruiting",TUBB,1
HIV-1 infection,PACLITAXEL,3,"Active, not recruiting",TUBB,1
HIV infection,PACLITAXEL,1,Terminated,TUBB,1
Gestational trophoblastic neoplasm,VINCRISTINE,3,Recruiting,TUBB,1
Gestational trophoblastic neoplasm,PACLITAXEL,3,Recruiting,TUBB,1
"Genital neoplasm, female",PACLITAXEL,1,Completed,TUBB,1
Gastrointestinal stromal tumor,PACLITAXEL,2,Completed,TUBB,1
Gastrointestinal stromal tumor,PACLITAXEL,1,"Active, not recruiting",TUBB,1
Fibrolamellar Carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
Hodgkins lymphoma,VINBLASTINE,2,Not yet recruiting,TUBB,1
Hodgkins lymphoma,VINBLASTINE,3,Recruiting,TUBB,1
Hodgkins lymphoma,VINBLASTINE,3,Unknown status,TUBB,1
Hodgkins lymphoma,VINBLASTINE,3,Withdrawn,TUBB,1
Malignant Ovarian Brenner Tumor,PACLITAXEL,1,"Active, not recruiting",TUBB,1
Malignant Ovarian Brenner Tumor,DOCETAXEL,1,Completed,TUBB,1
"Lymphoma, AIDS-Related",VINCRISTINE,2,Terminated,TUBB,1
"Lymphoma, AIDS-Related",VINCRISTINE,2,"Active, not recruiting",TUBB,1
"Lymphoma, AIDS-Related",VINCRISTINE,1,Completed,TUBB,1
Langerhans Cell Histiocytosis,VINBLASTINE,3,Recruiting,TUBB,1
Langerhans Cell Histiocytosis,VINBLASTINE,2,Recruiting,TUBB,1
Kaposi's sarcoma,PACLITAXEL,3,Completed,TUBB,1
Hodgkins lymphoma,VINORELBINE,3,Completed,TUBB,1
Hodgkins lymphoma,VINORELBINE,2,Unknown status,TUBB,1
Hodgkins lymphoma,VINORELBINE,2,Terminated,TUBB,1
Hodgkins lymphoma,VINORELBINE,2,Recruiting,TUBB,1
Hodgkins lymphoma,VINORELBINE,1,Unknown status,TUBB,1
Hodgkins lymphoma,VINCRISTINE,4,Unknown status,TUBB,1
Hodgkins lymphoma,VINCRISTINE,2,Unknown status,TUBB,1
Hodgkins lymphoma,VINCRISTINE,2,Terminated,TUBB,1
Hodgkins lymphoma,VINCRISTINE,2,Completed,TUBB,1
Hodgkins lymphoma,VINCRISTINE,1,Recruiting,TUBB,1
Hodgkins lymphoma,VINCRISTINE,1,Completed,TUBB,1
Familial Mediterranean fever,COLCHICINE,4,Completed,TUBB,1
Familial Mediterranean fever,COLCHICINE,2,Unknown status,TUBB,1
Familial Mediterranean fever,COLCHICINE,1,Completed,TUBB,1
Endometrial Undifferentiated Carcinoma,PACLITAXEL,1,Suspended,TUBB,1
Endometrial Serous Adenocarcinoma,PACLITAXEL,2,Unknown status,TUBB,1
Endometrial Serous Adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
Endometrial Serous Adenocarcinoma,MIRVETUXIMAB SORAVTANSINE,2,Not yet recruiting,TUBB,1
Endometrial Serous Adenocarcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB,1
Endometrial Mucinous Adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
Endometrial Endometrioid Adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
Endometrial Clear Cell Adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
Endometrial Clear Cell Adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
Endometrial Clear Cell Adenocarcinoma,MIRVETUXIMAB SORAVTANSINE,2,Not yet recruiting,TUBB,1
Endometrial Clear Cell Adenocarcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB,1
Cutaneous T-cell lymphoma,BRENTUXIMAB VEDOTIN,1,Recruiting,TUBB,1
Coronary Restenosis,PACLITAXEL,2,Recruiting,TUBB,1
Coronary Restenosis,PACLITAXEL,1,Completed,TUBB,1
Chronic Hepatitis C infection,COLCHICINE,2,Terminated,TUBB,1
Chemotherapy-induced nausea and vomiting,DOCETAXEL,1,Completed,TUBB,1
Burkitts lymphoma,VINCRISTINE,2,Terminated,TUBB,1
Burkitts lymphoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
Burkitts lymphoma,IXABEPILONE,2,Completed,TUBB,1
Behcet's syndrome,COLCHICINE,2,Completed,TUBB,1
Endometrial Squamous Cell Carcinoma,PACLITAXEL,1,Suspended,TUBB,1
Ewing sarcoma,VINCRISTINE,1,Completed,TUBB,1
Fallopian Tube Serous Adenocarcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
Ewing sarcoma,VINCRISTINE,2,Completed,TUBB,1
Fallopian Tube Serous Adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
Fallopian Tube Serous Adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
Fallopian Tube Serous Adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
Fallopian Tube Carcinosarcoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
Fallopian Tube Carcinoma,VINORELBINE,2,Completed,TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL POLIGLUMEX,1,Completed,TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL,3,Unknown status,TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL,3,Terminated,TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL,1,Unknown status,TUBB,1
Fallopian Tube Carcinoma,PACLITAXEL,1,Suspended,TUBB,1
Fallopian Tube Carcinoma,MIRVETUXIMAB SORAVTANSINE,1,Recruiting,TUBB,1
Fallopian Tube Carcinoma,IXABEPILONE,2,Recruiting,TUBB,1
Fallopian Tube Carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
Fallopian Tube Carcinoma,DOCETAXEL,2,Terminated,TUBB,1
Fallopian Tube Carcinoma,DOCETAXEL,1,Terminated,TUBB,1
Ewing sarcoma,VINCRISTINE,3,Recruiting,TUBB,1
Ewing sarcoma,VINCRISTINE,2,Recruiting,TUBB,1
Malignant Ovarian Brenner Tumor,PACLITAXEL,2,Completed,TUBB,1
Malignant Ovarian Brenner Tumor,PACLITAXEL,3,Completed,TUBB,1
Malignant Ovarian Brenner Tumor,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
acute lymphoblastic leukemia,VINCRISTINE,2,Not yet recruiting,TUBB,1
acute lymphoblastic leukemia,VINCRISTINE,1,"Active, not recruiting",TUBB,1
acute graft vs. host disease,BRENTUXIMAB VEDOTIN,2,Withdrawn,TUBB,1
acute graft vs. host disease,BRENTUXIMAB VEDOTIN,1,Terminated,TUBB,1
acute graft vs. host disease,BRENTUXIMAB VEDOTIN,1,Completed,TUBB,1
acute coronary syndrome,COLCHICINE,4,Unknown status,TUBB,1
acute coronary syndrome,COLCHICINE,2,Completed,TUBB,1
actinic keratosis,PACLITAXEL,2,"Active, not recruiting",TUBB,1
Waldenstrom macroglobulinemia,VINCRISTINE,1,Recruiting,TUBB,1
Vaginal neoplasm,VINORELBINE,1,Completed,TUBB,1
Vaginal neoplasm,PACLITAXEL,1,Completed,TUBB,1
Vaginal neoplasm,DOCETAXEL,1,Completed,TUBB,1
Uveal Melanoma,VINCRISTINE,2,Completed,TUBB,1
Uveal Melanoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
Uterine Carcinosarcoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
Tufted angioma,VINCRISTINE,2,Recruiting,TUBB,1
Transitional Cell Carcinoma,VINFLUNINE,2,Unknown status,TUBB,1
Transitional Cell Carcinoma,PACLITAXEL,1,Suspended,TUBB,1
Transitional Cell Carcinoma,DOCETAXEL,2,Completed,TUBB,1
Transitional Cell Carcinoma,CABAZITAXEL,2,Unknown status,TUBB,1
acute lymphoblastic leukemia,VINCRISTINE,1,Withdrawn,TUBB,1
acute lymphoblastic leukemia,VINCRISTINE,2,Unknown status,TUBB,1
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
acute lymphoblastic leukemia,VINCRISTINE,3,Suspended,TUBB,1
alveolar rhabdomyosarcoma,VINCRISTINE,3,Recruiting,TUBB,1
alveolar rhabdomyosarcoma,VINCRISTINE,2,Completed,TUBB,1
allergy,PACLITAXEL,3,Completed,TUBB,1
allergy,DOCETAXEL,3,Completed,TUBB,1
adult T acute lymphoblastic leukemia,VINCRISTINE,3,Suspended,TUBB,1
adrenal cortex carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
adrenal cortex carcinoma,CABAZITAXEL,2,Recruiting,TUBB,1
adenosquamous lung carcinoma,VINORELBINE,3,Completed,TUBB,1
adenosquamous lung carcinoma,PACLITAXEL,3,Completed,TUBB,1
adenosquamous lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
adenosarcoma,PACLITAXEL,1,Suspended,TUBB,1
adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,1
adenocarcinoma,PACLITAXEL,1,Terminated,TUBB,1
adenocarcinoma,PACLITAXEL,1,Completed,TUBB,1
acute myeloid leukemia,VINCRISTINE,3,Completed,TUBB,1
acute myeloid leukemia,VINCRISTINE,2,Not yet recruiting,TUBB,1
acute myeloid leukemia,VINCRISTINE,2,"Active, not recruiting",TUBB,1
acute myeloid leukemia,VINCRISTINE,1,Recruiting,TUBB,1
acute myeloid leukemia,BRENTUXIMAB VEDOTIN,1,"Active, not recruiting",TUBB,1
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
Thymoma,PACLITAXEL,2,Terminated,TUBB,1
Malignant Ovarian Mixed Epithelial Tumor,PACLITAXEL,3,Completed,TUBB,1
Primary Peritoneal Serous Adenocarcinoma,PACLITAXEL,1,Suspended,TUBB,1
Primary Peritoneal Serous Adenocarcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
Postpericardiotomy Syndrome,COLCHICINE,3,Completed,TUBB,1
Ovarian Transitional Cell Carcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
Ovarian Transitional Cell Carcinoma,PACLITAXEL,3,Completed,TUBB,1
Ovarian Transitional Cell Carcinoma,PACLITAXEL,1,Suspended,TUBB,1
Ovarian Transitional Cell Carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
Ocular Melanoma,PACLITAXEL,2,Completed,TUBB,1
Neurofibromatosis type 1,VINCRISTINE,2,Unknown status,TUBB,1
Neurofibromatosis type 1,VINBLASTINE,2,Completed,TUBB,1
Merkel cell skin cancer,PACLITAXEL,2,Terminated,TUBB,1
Merkel cell skin cancer,PACLITAXEL,1,Not yet recruiting,TUBB,1
Mantle cell lymphoma,VINCRISTINE,4,Recruiting,TUBB,1
Mantle cell lymphoma,VINCRISTINE,2,Recruiting,TUBB,1
Mantle cell lymphoma,VINCRISTINE,2,Not yet recruiting,TUBB,1
Mantle cell lymphoma,VINCRISTINE,1,Recruiting,TUBB,1
Mantle cell lymphoma,VINCRISTINE,1,"Active, not recruiting",TUBB,1
Mantle cell lymphoma,IXABEPILONE,2,Completed,TUBB,1
Malignant epithelial tumor of ovary,PACLITAXEL,1,Terminated,TUBB,1
Malignant epithelial tumor of ovary,DOCETAXEL,2,Completed,TUBB,1
Primary Peritoneal Serous Adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,1
Primary Peritoneal Serous Adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
Thymoma,PACLITAXEL,2,Completed,TUBB,1
Primary Peritoneal Serous Adenocarcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
Thymic Carcinoma,PACLITAXEL,2,Terminated,TUBB,1
Thymic Carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
Thymic Carcinoma,PACLITAXEL,2,Completed,TUBB,1
T-cell acute lymphoblastic leukemia,VINCRISTINE,4,Completed,TUBB,1
T-cell acute lymphoblastic leukemia,VINCRISTINE,3,Unknown status,TUBB,1
T-cell acute lymphoblastic leukemia,VINCRISTINE,2,Completed,TUBB,1
T-cell acute lymphoblastic leukemia,VINCRISTINE,1,Completed,TUBB,1
Small Intestinal Enteropathy-Associated T-Cell Lymphoma,BRENTUXIMAB VEDOTIN,2,Recruiting,TUBB,1
Sezary's disease,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,1
Sezary's disease,BRENTUXIMAB VEDOTIN,1,"Active, not recruiting",TUBB,1
ST Elevation Myocardial Infarction,COLCHICINE,3,Recruiting,TUBB,1
Retinoblastoma,VINCRISTINE,3,Unknown status,TUBB,1
Retinoblastoma,VINCRISTINE,3,Terminated,TUBB,1
Retinoblastoma,VINCRISTINE,3,Recruiting,TUBB,1
Retinoblastoma,VINCRISTINE,2,Unknown status,TUBB,1
Retinoblastoma,VINCRISTINE,2,"Active, not recruiting",TUBB,1
Retinoblastoma,VINCRISTINE,1,"Active, not recruiting",TUBB,1
Progressive supranuclear palsy,DAVUNETIDE,2,Completed,TUBB,1
Primary hemophagocytic lymphohistiocytosis,VINCRISTINE,2,"Active, not recruiting",TUBB,1
cervical carcinoma,DOCETAXEL,1,Terminated,TUBB,1
cervical carcinoma,DOCETAXEL,1,Withdrawn,TUBB,1
cervical carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
lung adenocarcinoma,DOCETAXEL,3,Terminated,TUBB,1
lung carcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
lung carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
lung carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
lung carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
lung adenocarcinoma,VINORELBINE,3,Completed,TUBB,1
lung adenocarcinoma,VINORELBINE,2,Recruiting,TUBB,1
lung adenocarcinoma,PACLITAXEL,3,Completed,TUBB,1
lung adenocarcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
lung adenocarcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
lung adenocarcinoma,DOCETAXEL,3,Completed,TUBB,1
cervical carcinoma,DOCETAXEL,3,Recruiting,TUBB,1
lung adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB,1
lung adenocarcinoma,DOCETAXEL,2,Completed,TUBB,1
lung adenocarcinoma,DOCETAXEL,1,Terminated,TUBB,1
leukemia,VINORELBINE,1,Completed,TUBB,1
leukemia,VINCRISTINE,3,Withdrawn,TUBB,1
leukemia,VINCRISTINE,1,Recruiting,TUBB,1
leukemia,VINBLASTINE,3,Completed,TUBB,1
leukemia,PACLITAXEL,2,Completed,TUBB,1
B-cell acute lymphoblastic leukemia,VINCRISTINE,2,Completed,TUBB,1
lung carcinoma,DOCETAXEL,2,Recruiting,TUBB,1
lung carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
lung carcinoma,IXABEPILONE,2,Withdrawn,TUBB,1
lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,1,Terminated,TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,1,Recruiting,TUBB,1
lymphoid neoplasm,BRENTUXIMAB VEDOTIN,1,Withdrawn,TUBB,1
lymphoid leukemia,VINCRISTINE,4,Completed,TUBB,1
lymphoid leukemia,VINCRISTINE,3,Completed,TUBB,1
lymphoid leukemia,VINCRISTINE,2,Unknown status,TUBB,1
lymphoid leukemia,VINCRISTINE,2,Enrolling by invitation,TUBB,1
lymphoid leukemia,VINCRISTINE,2,"Active, not recruiting",TUBB,1
lymphoid leukemia,VINCRISTINE,1,Terminated,TUBB,1
lymphoid leukemia,VINCRISTINE,1,Recruiting,TUBB,1
lung carcinoma,VINORELBINE,3,Withdrawn,TUBB,1
lung carcinoma,VINORELBINE,3,Terminated,TUBB,1
lung carcinoma,VINORELBINE,2,"Active, not recruiting",TUBB,1
lung carcinoma,VINORELBINE,1,Unknown status,TUBB,1
lung carcinoma,VINORELBINE,1,Terminated,TUBB,1
lung carcinoma,VINFLUNINE,2,Terminated,TUBB,1
lung carcinoma,VINCRISTINE,2,Terminated,TUBB,1
lung carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
lung carcinoma,PACLITAXEL,1,Unknown status,TUBB,1
leukemia,IXABEPILONE,2,Completed,TUBB,1
leukemia,DOCETAXEL,2,Completed,TUBB,1
leukemia,DOCETAXEL,1,Completed,TUBB,1
inflammatory breast carcinoma,ERIBULIN,2,Recruiting,TUBB,1
inflammatory breast carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
hypopharyngeal carcinoma,PACLITAXEL,1,Terminated,TUBB,1
hypopharyngeal carcinoma,IXABEPILONE,2,Completed,TUBB,1
hypopharyngeal carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
hypopharyngeal carcinoma,DOCETAXEL,2,Completed,TUBB,1
histiocytoma,VINCRISTINE,3,Completed,TUBB,1
high grade ovarian serous adenocarcinoma,PACLITAXEL,1,Recruiting,TUBB,1
hepatocellular carcinoma,PACLITAXEL,1,Recruiting,TUBB,1
hepatocellular carcinoma,PACLITAXEL,1,Completed,TUBB,1
hepatocellular carcinoma,DOCETAXEL,2,Terminated,TUBB,1
hepatocellular carcinoma,DOCETAXEL,2,Completed,TUBB,1
hemopericardium,COLCHICINE,4,Recruiting,TUBB,1
hemopericardium,COLCHICINE,4,Completed,TUBB,1
hemangioma,VINCRISTINE,2,Terminated,TUBB,1
heart disease,COLCHICINE,2,Recruiting,TUBB,1
head and neck squamous cell carcinoma,PACLITAXEL,2,Terminated,TUBB,1
head and neck squamous cell carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
head and neck squamous cell carcinoma,PACLITAXEL,1,Terminated,TUBB,1
head and neck squamous cell carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
inflammatory breast carcinoma,DOCETAXEL,3,Completed,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,1,Terminated,TUBB,1
leukemia,BRENTUXIMAB VEDOTIN,1,Terminated,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,2,Completed,TUBB,1
leiomyosarcoma,DOCETAXEL,2,Completed,TUBB,1
laryngeal squamous cell carcinoma,PACLITAXEL,1,Terminated,TUBB,1
laryngeal squamous cell carcinoma,IXABEPILONE,2,Completed,TUBB,1
laryngeal neoplasm,DOCETAXEL,3,Completed,TUBB,1
laryngeal neoplasm,DOCETAXEL,2,Unknown status,TUBB,1
laryngeal neoplasm,DOCETAXEL,2,"Active, not recruiting",TUBB,1
large cell neuroendocrine carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
large cell lung carcinoma,VINORELBINE,2,Recruiting,TUBB,1
large cell lung carcinoma,PACLITAXEL,3,Terminated,TUBB,1
large cell lung carcinoma,PACLITAXEL,2,Terminated,TUBB,1
large cell lung carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
large cell lung carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
large cell lung carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
ischemia,PACLITAXEL,3,Completed,TUBB,1
invasive ductal carcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
intrahepatic cholangiocarcinoma,PACLITAXEL,2,Recruiting,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,3,Terminated,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,3,Recruiting,TUBB,1
inflammatory breast carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,1,Withdrawn,TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,2,"Active, not recruiting",TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,1
metastatic melanoma,VINORELBINE,2,Completed,TUBB,1
metastatic melanoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
metastatic melanoma,PACLITAXEL,2,Withdrawn,TUBB,1
metastatic melanoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
metastatic melanoma,DOCETAXEL,2,Completed,TUBB,1
metastatic melanoma,DOCETAXEL,1,Completed,TUBB,1
metastatic colorectal cancer,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,1
metastatic colorectal cancer,PACLITAXEL,1,Recruiting,TUBB,1
metastatic colorectal cancer,DOCETAXEL,2,"Active, not recruiting",TUBB,1
metastasis,VINCRISTINE,1,"Active, not recruiting",TUBB,1
metastasis,TRASTUZUMAB EMTANSINE,2,Recruiting,TUBB,1
metastasis,PACLITAXEL,2,Recruiting,TUBB,1
metastasis,PACLITAXEL,1,Completed,TUBB,1
metastasis,DOCETAXEL,2,Recruiting,TUBB,1
mesothelioma,VINORELBINE,3,Completed,TUBB,1
mesothelioma,VINORELBINE,2,Terminated,TUBB,1
mesothelioma,VINORELBINE,2,Recruiting,TUBB,1
mesothelioma,VINORELBINE,2,"Active, not recruiting",TUBB,1
mesothelioma,VINCRISTINE,3,Completed,TUBB,1
mesothelioma,VINBLASTINE,2,Unknown status,TUBB,1
metastatic melanoma,VINBLASTINE,2,Terminated,TUBB,1
metastatic prostate cancer,CABAZITAXEL,2,Not yet recruiting,TUBB,1
melanoma,VINCRISTINE,1,Completed,TUBB,1
metastatic prostate cancer,CABAZITAXEL,2,Recruiting,TUBB,1
mycosis fungoides,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,1
mycosis fungoides,BRENTUXIMAB VEDOTIN,1,"Active, not recruiting",TUBB,1
multiple myeloma,VINORELBINE,2,Recruiting,TUBB,1
multiple myeloma,VINORELBINE,2,Completed,TUBB,1
multiple myeloma,VINCRISTINE,3,Terminated,TUBB,1
multiple myeloma,VINCRISTINE,2,Terminated,TUBB,1
multiple myeloma,VINCRISTINE,1,Recruiting,TUBB,1
multiple myeloma,VINCRISTINE,1,Completed,TUBB,1
multiple myeloma,PACLITAXEL,2,Withdrawn,TUBB,1
multiple myeloma,PACLITAXEL,2,Terminated,TUBB,1
multiple myeloma,PACLITAXEL,1,Terminated,TUBB,1
multiple myeloma,LEXIBULIN,2,Terminated,TUBB,1
multiple myeloma,DOCETAXEL,1,Completed,TUBB,1
mouth neoplasm,PACLITAXEL,2,Completed,TUBB,1
metastatic prostate cancer,DOCETAXEL,3,"Active, not recruiting",TUBB,1
metastatic prostate cancer,DOCETAXEL,2,Terminated,TUBB,1
metastatic prostate cancer,DOCETAXEL,2,"Active, not recruiting",TUBB,1
metastatic prostate cancer,DOCETAXEL,1,Recruiting,TUBB,1
metastatic prostate cancer,CABAZITAXEL,2,Withdrawn,TUBB,1
mesothelioma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
melanoma,VINBLASTINE,3,Completed,TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,2,Terminated,TUBB,1
male breast carcinoma,IXABEPILONE,2,Completed,TUBB,1
male breast carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB,1
male breast carcinoma,DOCETAXEL,1,Terminated,TUBB,1
lymphoma,VINORELBINE,3,Terminated,TUBB,1
lymphoma,VINORELBINE,2,Withdrawn,TUBB,1
lymphoma,VINORELBINE,2,"Active, not recruiting",TUBB,1
lymphoma,VINCRISTINE,3,Suspended,TUBB,1
lymphoma,VINCRISTINE,1,Withdrawn,TUBB,1
lymphoma,VINCRISTINE,1,Terminated,TUBB,1
lymphoma,VINCRISTINE,1,Recruiting,TUBB,1
lymphoma,VINCRISTINE,1,"Active, not recruiting",TUBB,1
lymphoma,VINBLASTINE,4,Unknown status,TUBB,1
lymphoma,VINBLASTINE,2,Terminated,TUBB,1
lymphoma,VINBLASTINE,1,Not yet recruiting,TUBB,1
lymphoma,VINBLASTINE,1,Completed,TUBB,1
lymphoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
lymphoma,IXABEPILONE,2,Completed,TUBB,1
lymphoma,ERIBULIN,1,Completed,TUBB,1
lymphoma,DOCETAXEL,1,Completed,TUBB,1
lymphoma,BRENTUXIMAB VEDOTIN,4,Recruiting,TUBB,1
male breast carcinoma,IXABEPILONE,1,"Active, not recruiting",TUBB,1
male breast carcinoma,PACLITAXEL,1,Terminated,TUBB,1
melanoma,VINBLASTINE,2,Terminated,TUBB,1
male breast carcinoma,PACLITAXEL,2,Completed,TUBB,1
melanoma,VINBLASTINE,2,Completed,TUBB,1
melanoma,VINBLASTINE,1,Completed,TUBB,1
melanoma,SAGOPILONE,2,Completed,TUBB,1
melanoma,PACLITAXEL,3,Unknown status,TUBB,1
melanoma,PACLITAXEL,3,Completed,TUBB,1
melanoma,PACLITAXEL,2,Unknown status,TUBB,1
melanoma,PACLITAXEL,1,Withdrawn,TUBB,1
melanoma,PACLITAXEL,1,Unknown status,TUBB,1
melanoma,PACLITAXEL,1,Terminated,TUBB,1
melanoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
melanoma,IXABEPILONE,2,Completed,TUBB,1
melanoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
melanoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
medulloblastoma,VINCRISTINE,3,Suspended,TUBB,1
mediastinal cancer,DOCETAXEL,2,Terminated,TUBB,1
malignant pleural mesothelioma,VINORELBINE,3,"Active, not recruiting",TUBB,1
malignant pleural mesothelioma,VINORELBINE,2,Completed,TUBB,1
male breast carcinoma,VINORELBINE,2,Completed,TUBB,1
male breast carcinoma,PACLITAXEL,2,Recruiting,TUBB,1
head and neck squamous cell carcinoma,PACLITAXEL,1,Completed,TUBB,1
head and neck squamous cell carcinoma,DOCETAXEL,3,Recruiting,TUBB,1
head and neck squamous cell carcinoma,DOCETAXEL,3,Completed,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,2,Not yet recruiting,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,1,Suspended,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,1,Not yet recruiting,TUBB,1
diffuse large B-cell lymphoma,VINBLASTINE,3,Completed,TUBB,1
diffuse large B-cell lymphoma,IXABEPILONE,2,Completed,TUBB,1
diffuse large B-cell lymphoma,BRENTUXIMAB VEDOTIN,2,Recruiting,TUBB,1
diffuse large B-cell lymphoma,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,1
diffuse large B-cell lymphoma,BRENTUXIMAB VEDOTIN,1,Not yet recruiting,TUBB,1
diffuse intrinsic pontine glioma,VINORELBINE,2,Recruiting,TUBB,1
diabetic nephropathy,COLCHICINE,2,Unknown status,TUBB,1
diabetic nephropathy,COLCHICINE,1,Recruiting,TUBB,1
dedifferentiated liposarcoma,CABAZITAXEL,2,Recruiting,TUBB,1
cutaneous squamous cell carcinoma,PACLITAXEL,2,Terminated,TUBB,1
cutaneous melanoma,VINORELBINE,2,Completed,TUBB,1
cutaneous melanoma,VINBLASTINE,1,Completed,TUBB,1
cutaneous melanoma,PACLITAXEL,3,Completed,TUBB,1
cutaneous melanoma,PACLITAXEL,2,Terminated,TUBB,1
cutaneous melanoma,PACLITAXEL,2,Suspended,TUBB,1
cutaneous melanoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
cutaneous melanoma,PACLITAXEL,1,Suspended,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,2,Enrolling by invitation,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,2,Withdrawn,TUBB,1
coronary artery disease,PACLITAXEL,4,Completed,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,3,Withdrawn,TUBB,1
endometrial neoplasm,IXABEPILONE,3,Terminated,TUBB,1
endometrial neoplasm,DOCETAXEL,2,Unknown status,TUBB,1
endometrial neoplasm,DOCETAXEL,2,Recruiting,TUBB,1
endometrial carcinoma,PACLITAXEL,2,Completed,TUBB,1
endometrial carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
endometrial adenosquamous carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
endometrial adenosquamous carcinoma,IXABEPILONE,2,"Active, not recruiting",TUBB,1
embryonal rhabdomyosarcoma,VINORELBINE,3,Recruiting,TUBB,1
embryonal rhabdomyosarcoma,VINCRISTINE,3,Recruiting,TUBB,1
embryonal rhabdomyosarcoma,VINCRISTINE,2,Completed,TUBB,1
dysplasia of cervix,PACLITAXEL,2,Withdrawn,TUBB,1
ductal adenocarcinoma,DOCETAXEL,2,Terminated,TUBB,1
drug-induced liver injury,DOCETAXEL,4,Unknown status,TUBB,1
digestive system disease,PACLITAXEL,2,Terminated,TUBB,1
digestive system disease,DOCETAXEL,1,Completed,TUBB,1
diffuse scleroderma,BRENTUXIMAB VEDOTIN,2,Not yet recruiting,TUBB,1
diffuse large B-cell lymphoma,VINORELBINE,2,Recruiting,TUBB,1
diffuse large B-cell lymphoma,VINORELBINE,2,Completed,TUBB,1
diffuse large B-cell lymphoma,VINCRISTINE,4,Unknown status,TUBB,1
cutaneous melanoma,PACLITAXEL,1,Recruiting,TUBB,1
coronary artery disease,PACLITAXEL,4,"Active, not recruiting",TUBB,1
endometrial neoplasm,PACLITAXEL,2,Not yet recruiting,TUBB,1
chronic kidney disease,COLCHICINE,4,Completed,TUBB,1
choroid plexus cancer,VINCRISTINE,3,Completed,TUBB,1
childhood supratentorial ependymoma,VINCRISTINE,3,Recruiting,TUBB,1
childhood T acute lymphoblastic leukemia,VINCRISTINE,3,Suspended,TUBB,1
childhood T acute lymphoblastic leukemia,VINCRISTINE,3,Completed,TUBB,1
childhood T acute lymphoblastic leukemia,VINCRISTINE,2,Completed,TUBB,1
childhood T acute lymphoblastic leukemia,VINCRISTINE,1,Completed,TUBB,1
childhood B acute lymphoblastic leukemia,VINCRISTINE,2,Suspended,TUBB,1
childhood B acute lymphoblastic leukemia,VINCRISTINE,2,Completed,TUBB,1
childhood B acute lymphoblastic leukemia,VINCRISTINE,1,Completed,TUBB,1
cervical squamous cell carcinoma,PACLITAXEL,1,Suspended,TUBB,1
cervical squamous cell carcinoma,DOCETAXEL,2,Completed,TUBB,1
cervical carcinoma,VINORELBINE,2,Completed,TUBB,1
cervical carcinoma,VINORELBINE,1,Completed,TUBB,1
cervical carcinoma,VINCRISTINE,3,Completed,TUBB,1
cervical carcinoma,VINBLASTINE,3,Completed,TUBB,1
cervical carcinoma,PACLITAXEL,3,Withdrawn,TUBB,1
cervical carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
cervical carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
cervical carcinoma,ERIBULIN,2,"Active, not recruiting",TUBB,1
choroid plexus cancer,VINCRISTINE,3,Suspended,TUBB,1
chronic lymphocytic leukemia,VINCRISTINE,0,Terminated,TUBB,1
coronary artery disease,COLCHICINE,4,Recruiting,TUBB,1
chronic lymphocytic leukemia,VINCRISTINE,1,Recruiting,TUBB,1
coronary artery disease,COLCHICINE,2,Recruiting,TUBB,1
colorectal carcinoma,VINCRISTINE,3,Completed,TUBB,1
colorectal carcinoma,VINCRISTINE,1,Completed,TUBB,1
colorectal carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
colorectal carcinoma,PACLITAXEL,2,Completed,TUBB,1
colorectal carcinoma,PACLITAXEL,1,Not yet recruiting,TUBB,1
colorectal carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
colorectal carcinoma,IXABEPILONE,2,Terminated,TUBB,1
colorectal carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
colorectal carcinoma,CABAZITAXEL,2,Terminated,TUBB,1
colorectal cancer,PACLITAXEL POLIGLUMEX,1,Completed,TUBB,1
colorectal cancer,DOCETAXEL,2,Completed,TUBB,1
colorectal adenocarcinoma,PACLITAXEL,2,Completed,TUBB,1
colon carcinoma,VINORELBINE,2,Recruiting,TUBB,1
colon carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
clear cell renal carcinoma,IXABEPILONE,2,Completed,TUBB,1
cirrhosis of liver,COLCHICINE,1,Unknown status,TUBB,1
chronic myeloproliferative disorder,DOCETAXEL,1,Completed,TUBB,1
chronic lymphocytic leukemia,VINCRISTINE,2,Completed,TUBB,1
endometrial neoplasm,PACLITAXEL,1,Recruiting,TUBB,1
endometrial neoplasm,PACLITAXEL,2,Terminated,TUBB,1
head and neck squamous cell carcinoma,CABAZITAXEL,2,Completed,TUBB,1
glioblastoma multiforme,PACLITAXEL,1,Terminated,TUBB,1
glioblastoma multiforme,CABAZITAXEL,2,Completed,TUBB,1
germ cell tumor,PACLITAXEL,2,Completed,TUBB,1
germ cell tumor,PACLITAXEL,1,Withdrawn,TUBB,1
germ cell tumor,DOCETAXEL,2,Completed,TUBB,1
germ cell tumor,BRENTUXIMAB VEDOTIN,2,Suspended,TUBB,1
germ cell tumor,BRENTUXIMAB VEDOTIN,2,Completed,TUBB,1
gastric carcinoma,TRASTUZUMAB EMTANSINE,2,Terminated,TUBB,1
gastric carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
gastric carcinoma,PACLITAXEL,2,"Active, not recruiting",TUBB,1
gastric carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
gastric carcinoma,PACLITAXEL,1,Terminated,TUBB,1
gastric carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
gastric carcinoma,DOCETAXEL,3,Not yet recruiting,TUBB,1
gastric carcinoma,DOCETAXEL,3,Enrolling by invitation,TUBB,1
gastric carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
gastric carcinoma,DOCETAXEL,1,Suspended,TUBB,1
gastric carcinoma,CABAZITAXEL,2,Completed,TUBB,1
gastric carcinoma,CABAZITAXEL,1,Completed,TUBB,1
gastric adenocarcinoma,PACLITAXEL,3,"Active, not recruiting",TUBB,1
glioblastoma multiforme,LEXIBULIN,1,Terminated,TUBB,1
glioblastoma multiforme,SAGOPILONE,2,Completed,TUBB,1
gastric adenocarcinoma,PACLITAXEL,1,Completed,TUBB,1
glioblastoma multiforme,VINCRISTINE,2,Completed,TUBB,1
head and neck squamous cell carcinoma,CABAZITAXEL,1,Completed,TUBB,1
head and neck malignant neoplasia,VINFLUNINE,3,Completed,TUBB,1
head and neck malignant neoplasia,VINCRISTINE,3,Completed,TUBB,1
head and neck malignant neoplasia,PACLITAXEL,3,Terminated,TUBB,1
head and neck malignant neoplasia,PACLITAXEL,3,"Active, not recruiting",TUBB,1
head and neck malignant neoplasia,PACLITAXEL,2,Withdrawn,TUBB,1
head and neck malignant neoplasia,PACLITAXEL,1,Terminated,TUBB,1
head and neck malignant neoplasia,IXABEPILONE,1,Completed,TUBB,1
head and neck malignant neoplasia,FOSBRETABULIN,2,Completed,TUBB,1
head and neck malignant neoplasia,FOSBRETABULIN,1,Terminated,TUBB,1
head and neck malignant neoplasia,ERIBULIN,2,Completed,TUBB,1
head and neck malignant neoplasia,DOCETAXEL,4,Unknown status,TUBB,1
head and neck malignant neoplasia,DOCETAXEL,3,Withdrawn,TUBB,1
head and neck malignant neoplasia,DOCETAXEL,2,Withdrawn,TUBB,1
head and neck malignant neoplasia,DOCETAXEL,1,Unknown status,TUBB,1
head and neck malignant neoplasia,DOCETAXEL,1,Terminated,TUBB,1
head and neck malignant neoplasia,CABAZITAXEL,2,Completed,TUBB,1
gout,COLCHICINE,1,Recruiting,TUBB,1
gliosarcoma,IXABEPILONE,1,Completed,TUBB,1
gastric adenocarcinoma,PACLITAXEL,2,Unknown status,TUBB,1
gastric adenocarcinoma,DOCETAXEL,3,Recruiting,TUBB,1
endometrial neoplasm,PACLITAXEL,3,"Active, not recruiting",TUBB,1
esophageal carcinoma,DOCETAXEL,3,Completed,TUBB,1
esophageal carcinoma,DOCETAXEL,2,Recruiting,TUBB,1
esophageal carcinoma,DOCETAXEL,2,Not yet recruiting,TUBB,1
esophageal carcinoma,DOCETAXEL,1,Unknown status,TUBB,1
esophageal carcinoma,DOCETAXEL,1,"Active, not recruiting",TUBB,1
esophageal adenocarcinoma,PACLITAXEL,2,Terminated,TUBB,1
esophageal adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,1
ependymoma,VINCRISTINE,2,Recruiting,TUBB,1
endometrium adenocarcinoma,PACLITAXEL,2,Unknown status,TUBB,1
endometrium adenocarcinoma,PACLITAXEL,2,Recruiting,TUBB,1
endometrium adenocarcinoma,IXABEPILONE,2,Completed,TUBB,1
endometrium adenocarcinoma,DOCETAXEL,2,Completed,TUBB,1
endometrioid carcinoma,PACLITAXEL POLIGLUMEX,3,"Active, not recruiting",TUBB,1
endometrioid carcinoma,PACLITAXEL,3,Completed,TUBB,1
endometrioid carcinoma,PACLITAXEL,2,Completed,TUBB,1
endometrioid carcinoma,PACLITAXEL,1,Suspended,TUBB,1
endometrioid carcinoma,PACLITAXEL,1,Recruiting,TUBB,1
endometrioid carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
endometrioid carcinoma,DOCETAXEL,1,Completed,TUBB,1
endometrial neoplasm,VINORELBINE,1,Completed,TUBB,1
esophageal carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
esophageal carcinoma,DOCETAXEL,3,Recruiting,TUBB,1
gastric adenocarcinoma,DOCETAXEL,2,Recruiting,TUBB,1
esophageal carcinoma,PACLITAXEL,1,"Active, not recruiting",TUBB,1
gastric adenocarcinoma,DOCETAXEL,2,"Active, not recruiting",TUBB,1
esophageal squamous cell carcinoma,VINORELBINE,3,Recruiting,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,3,Unknown status,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,3,Not yet recruiting,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,3,Completed,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,2,Withdrawn,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,2,Unknown status,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,2,Suspended,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,2,Completed,TUBB,1
esophageal squamous cell carcinoma,PACLITAXEL,1,Recruiting,TUBB,1
esophageal squamous cell carcinoma,DOCETAXEL,3,"Active, not recruiting",TUBB,1
esophageal squamous cell carcinoma,DOCETAXEL,2,Unknown status,TUBB,1
esophageal squamous cell carcinoma,DOCETAXEL,1,Recruiting,TUBB,1
esophageal squamous cell carcinoma,DOCETAXEL,1,Completed,TUBB,1
esophageal carcinoma,PACLITAXEL,3,Withdrawn,TUBB,1
esophageal carcinoma,PACLITAXEL,3,Unknown status,TUBB,1
esophageal carcinoma,PACLITAXEL,2,Not yet recruiting,TUBB,1
esophageal carcinoma,PACLITAXEL,1,Withdrawn,TUBB,1
esophageal carcinoma,PACLITAXEL,1,Terminated,TUBB,1
vulvar carcinoma,PACLITAXEL,2,Completed,TUBB,1
